David Findlay

Research Interests

Cell Biology Orthopaedics

David Findlay

School of Pharmacy and Biomedical Science

College of Health

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.

David Findlay is Professor of Orthopaedic Research in the Discipline of Orthopaedics and Trauma at The University of Adelaide. His undergraduate and postgraduate studies were at The University of Melbourne, followed by postdoctoral work at the National Institutes of Health, Maryland, USA. He has worked in bone and joint research for over 30 years, focusing on the mechanisms of pathological bone loss, both systemic, such as in osteoporosis, or focal, such as in bone cancer or around orthopaedic implants.

Date Position Institution name
1996 - ongoing Professor of Orthopaedic Research University of Adelaide

Date Institution name Country Title
1979 - 1982 University of Melbourne Australia PhD
1974 - 1977 University of Melbourne Australia MSc
1970 - 1972 University of Melbourne Australia BSc

Date Title Institution Country
1985 - 1987 Post-doctoral training National Institutes of Health (NIH) United States

Year Citation
2024 Muratovic, D., Atkins, G. J., & Findlay, D. M. (2024). Is RANKL a potential molecular target in osteoarthritis?. Osteoarthritis and Cartilage, 32(5), 493-500.
DOI Scopus12 WoS11 Europe PMC9
2023 Muratovic, D., Findlay, D. M., Quinn, M. J., Quarrington, R. D., Solomon, L. B., & Atkins, G. J. (2023). Microstructural and cellular characterisation of the subchondral trabecular bone in human knee and hip osteoarthritis using synchrotron tomography. Osteoarthritis and Cartilage, 31(9), 1224-1233.
DOI Scopus5 WoS5 Europe PMC1
2022 Quintieri, L., Lilley, S., Wilcox, D., Findlay, D., Jenkins, D., Gallimore, S., & Haynes, D. (2022). Decay heat in ISIS spallation target: simulations and measurements. Journal of Neutron Research, 24(3-4), 313-327.
DOI
2022 Ormsby, R. T., Hosaka, K., Evdokiou, A., Odysseos, A., Findlay, D. M., Solomon, L. B., & Atkins, G. J. (2022). The Effects of Vitamin E Analogues α-Tocopherol and γ-Tocotrienol on the Human Osteocyte Response to Ultra-High Molecular Weight Polyethylene Wear Particles. Prosthesis, 4(3), 480-489.
DOI Scopus2 WoS2
2022 Dorraki, M., Muratovic, D., Fouladzadeh, A., Verjans, J. W., Allison, A., Findlay, D. M., & Abbott, D. (2022). Hip osteoarthritis: A novel network analysis of subchondral trabecular bone structures. PNAS Nexus, 1(5), pgac258-1-pgac258-11.
DOI Scopus4 WoS3 Europe PMC2
2022 Muratovic, D., Findlay, D. M., Quarrington, R. D., Cao, X., Solomon, L. B., Atkins, G. J., & Kuliwaba, J. S. (2022). Elevated levels of active Transforming Growth Factor β1 in the subchondral bone relate spatially to cartilage loss and impaired bone quality in human knee osteoarthritis. Osteoarthritis and Cartilage, 30(6), 896-907.
DOI Scopus17 WoS15 Europe PMC10
2022 Hofstaetter, J. G., Atkins, G. J., Kato, H., Kogawa, M., Blouin, S., Misof, B. M., . . . Ito, N. (2022). A Mild Case of Autosomal Recessive Osteopetrosis Masquerading as the Dominant Form Involving Homozygous Deep Intronic Variations in the CLCN7 Gene. Calcified Tissue International, 111(4), 430-444.
DOI Scopus3 WoS3 Europe PMC3
2021 Lee, Y. -R., Findlay, D. M., Muratovic, D., & Kuliwaba, J. S. (2021). Greater heterogeneity of the bone mineralisation density distribution and low bone matrix mineralisation characterise tibial subchondral bone marrow lesions in knee osteoarthritis patients. Bone, 149, 1-10.
DOI Scopus10 WoS9 Europe PMC5
2020 Lee, Y., Findlay, D., Muratovic, D., Gill, T., & Kuliwaba, J. (2020). Raman microspectroscopy demonstrates reduced mineralization of subchondral bone marrow lesions in knee osteoarthritis patients. Bone Reports, 12, 100269-1-100269-9.
DOI Scopus8 WoS6 Europe PMC4
2019 Muratovic, D., Findlay, D. M., Cicuttini, F. M., Wluka, A. E., Lee, Y. R., Edwards, S., & Kuliwaba, J. S. (2019). Bone marrow lesions in knee osteoarthritis: regional differences in tibial subchondral bone microstructure and their association with cartilage degeneration. Osteoarthritis and Cartilage, 27(11), 1653-1662.
DOI Scopus40 WoS38 Europe PMC35
2019 Ormsby, R. T., Solomon, L. B., Stamenkov, R., Findlay, D. M., & Atkins, G. J. (2019). Evidence for gender-specific bone loss mechanisms in periprosthetic osteolysis. Journal of Clinical Medicine, 9(1), 1-15.
DOI Scopus7 WoS7 Europe PMC3
2019 Ormsby, R. T., Solomon, L. B., Yang, D., Crotti, T. N., Haynes, D. R., Findlay, D. M., & Atkins, G. J. (2019). Osteocytes respond to particles of clinically-relevant conventional and cross-linked polyethylene and metal alloys by up-regulation of resorptive and inflammatory pathways. Acta Biomaterialia, 87, 296-306.
DOI Scopus55 WoS46 Europe PMC39
2019 Zhu, S., Zhu, J., Zhen, G., Hu, Y., An, S., Li, Y., . . . Cao, X. (2019). Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. Journal of Clinical Investigation, 129(3), 1076-1093.
DOI Scopus358 WoS337 Europe PMC331
2018 Alliston, T., Hernandez, C. J., Findlay, D. M., Felson, D. T., & Kennedy, O. D. (2018). Bone marrow lesions in osteoarthritis: what lies beneath. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 36(7), 1818-1825.
DOI Scopus70 WoS56 Europe PMC56
2018 Muratovic, D., Findlay, D., Cicuttini, F., Wluka, A., Lee, Y. -R., & Kuliwaba, J. (2018). Bone matrix microdamage and vascular changes characterize bone marrow lesions in the subchondral bone of knee osteoarthritis. Bone, 108, 193-201.
DOI Scopus60 WoS53 Europe PMC46
2018 Yang, D., Wijenayaka, A., Solomon, L., Pederson, S., Findlay, D., Kidd, S., & Atkins, G. (2018). Novel insights into Staphylococcus aureus deep bone infections: the involvement of osteocytes. mBio, 9(2), e00415-18-1-e00415-18-10.
DOI Scopus143 WoS135 Europe PMC116
2018 Yang, D., Anderson, P., Wijenayaka, A., Barratt, K., Triliana, R., Stapledon, C., . . . Atkins, G. (2018). Both ligand and VDR expression levels critically determine the effect of 1α,25-dihydroxyvitamin-D₃ on osteoblast differentiation. Journal of Steroid Biochemistry and Molecular Biology, 177, 83-90.
DOI Scopus17 WoS13 Europe PMC11
2018 Kogawa, M., Khalid, K., Wijenayaka, A., Ormsby, R., Evdokiou, A., Anderson, P., . . . Atkins, G. (2018). Recombinant sclerostin antagonises effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size. American Journal of Physiology - Cell Physiology, 314(1), 53-61.
DOI Scopus29 WoS27 Europe PMC22
2017 Daish, C., Blanchard, R., Gulati, K., Losic, D., Findlay, D., Harvie, D., & Pivonka, P. (2017). Estimation of anisotropic permeability in trabecular bone based on microCT imaging and pore-scale fluid dynamics simulations. Bone Reports, 6, 129-139.
DOI Scopus34 Europe PMC15
2017 Thewlis, D., Fraysse, F., Callary, S., Verghese, V., Jones, C., Findlay, D., . . . Solomon, L. (2017). Postoperative weight bearing and patient reported outcomes at one year following tibial plateau fractures. Injury, 48(7), 1650-1656.
DOI Scopus34 WoS28 Europe PMC27
2017 Liapis, V., Zysk, A., DeNichilo, M., Zinonos, I., Hay, S., Panagopoulos, V., . . . Evdokiou, A. (2017). Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma. Cancer Medicine, 6(9), 2164-2176.
DOI Scopus9 WoS9 Europe PMC8
2017 Clark, J., & Findlay, D. (2017). Musculoskeletal health in the context of spinal cord injury. Current Osteoporosis Reports, 15(5), 433-442.
DOI Scopus23 WoS22 Europe PMC19
2017 Panagopoulos, V., Liapis, V., Zinonos, I., Hay, S., Leach, D. A., Ingman, W., . . . Evdokiou, A. (2017). Peroxidase enzymes inhibit osteoclast differentiation and bone resorption. Molecular and Cellular Endocrinology, 440(C), 8-15.
DOI Scopus17 WoS18 Europe PMC15
2017 Zysk, A., DeNichilo, M., Panagopoulos, V., Zinonos, I., Liapis, V., Hay, S., . . . Evdokiou, A. (2017). Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer. Cancer Letters, 386, 141-150.
DOI Scopus23 WoS21 Europe PMC20
2017 Gulati, K., Prideaux, M., Kogawa, M., Lima-Marques, L., Atkins, G. J., Findlay, D. M., & Losic, D. (2017). Anodized 3D-printed titanium implants with dual micro- and nano-scale topography promote interaction with human osteoblasts and osteocyte-like cells. Journal of Tissue Engineering and Regenerative Medicine, 11(12), 3313-3325.
DOI Scopus94 WoS85 Europe PMC51
2016 Findlay, D., & Kuliwaba, J. (2016). Bone-cartilage crosstalk: a conversation for understanding osteoarthritis. Bone Research, 4(1), 1-12.
DOI Scopus222 WoS214 Europe PMC164
2016 Saad, S., Dharmapatni, A., Crotti, T., Cantley, M., Algate, K., Findlay, D., . . . Haynes, D. (2016). Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss. Acta Biomaterialia, 30, 311-318.
DOI Scopus22 WoS20 Europe PMC18
2016 DeNichilo, M., Shoubridge, A., Panagopoulos, V., Liapis, V., Zysk, A., Zinonos, I., . . . Evdokiou, A. (2016). Peroxidase enzymes regulate collagen biosynthesis and matrix mineralization by cultured human osteoblasts. Calcified Tissue International, 98(3), 294-305.
DOI Scopus14 WoS15 Europe PMC14
2016 Wijenayaka, A., Prideaux, M., Yang, D., Morris, H., Findlay, D., Anderson, P., & Atkins, G. (2016). Early response of the human SOST gene to stimulation by 1α,25-dihydroxyvitamin D₃. Journal of Steroid Biochemistry and Molecular Biology, 164, 369-373.
DOI Scopus14 WoS11 Europe PMC13
2016 Liapis, V., Zinonos, I., Labrinidis, A., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2016). Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models. Cancer Medicine, 5(3), 534-545.
DOI Scopus27 WoS24 Europe PMC22
2016 Gulati, K., Maher, S., Chandrasekaran, S., Findlay, D., & Losic, D. (2016). Conversion of titania (TiO2) into conductive titanium (Ti) nanotube arrays for combined drug-delivery and electrical stimulation therapy. Journal of Materials Chemistry B, 4(3), 371-375.
DOI Scopus42 WoS33 Europe PMC16
2016 Ormsby, R., Cantley, M., Kogawa, M., Solomon, L., Haynes, D., Findlay, D., & Atkins, G. (2016). Evidence that osteocyte perilacunar remodelling contributes to polyethylene wear particle induced osteolysis. Acta Biomaterialia, 33, 242-251.
DOI Scopus66 WoS57 Europe PMC43
2016 Muratovic, D., Cicuttini, F., Wluka, A., Findlay, D., Wang, Y., Otto, S., . . . Kuliwaba, J. (2016). Bone marrow lesions detected by specific combination of MRI sequences are associated with severity of osteochondral degeneration. Arthritis Research and Therapy, 18(1), 54-1-54-11.
DOI Scopus55 WoS53 Europe PMC45
2016 Prideaux, M., Findlay, D., & Atkins, G. (2016). Osteocytes: the master cells in bone remodelling. Current Opinion in Pharmacology, 28, 24-30.
DOI Scopus171 WoS163 Europe PMC132
2016 Briggs, M., Kuliwaba, J., Muratovic, D., Everest-Dass, A., Packer, N., Findlay, D., & Hoffmann, P. (2016). MALDI mass spectrometry imaging of N-glycans on tibial cartilage and subchondral bone proteins in knee osteoarthritis. Proteomics, 16(11-12), 1736-1741.
DOI Scopus44 WoS42 Europe PMC39
2016 Gulati, K., Johnson, L., Karunagaran, R., Findlay, D., & Losic, D. (2016). In situ transformation of chitosan films into microtubular structures on the surface of nanoengineered titanium implants. Biomacromolecules, 17(4), 1261-1271.
DOI Scopus19 WoS15 Europe PMC8
2016 Prideaux, M., Schutz, C., Wijenayaka, A. R., Findlay, D. M., Campbell, D. G., Solomon, L. B., & Atkins, G. J. (2016). Isolation of osteocytes from human trabecular bone. Bone, 88, 64-72.
DOI Scopus37 WoS33 Europe PMC31
2016 Gulati, K., Maher, S., Findlay, D., & Losic, D. (2016). Titania nanotubes for orchestrating osteogenesis at the bone-implant interface. Nanomedicine, 11(14), 1847-1864.
DOI Scopus82 WoS75 Europe PMC50
2016 Gulati, K., Kogawa, M., Prideaux, M., Findlay, D., Atkins, G., & Losic, D. (2016). Drug-releasing nano-engineered titanium implants: therapeutic efficacy in 3D cell culture model, controlled release and stability. Materials Science and Engineering C, 69, 831-840.
DOI Scopus65 WoS54 Europe PMC30
2016 Rahman, S., Gulati, K., Kogawa, M., Atkins, G., Pivonka, P., Findlay, D., & Losic, D. (2016). Drug diffusion, integration, and stability of nanoengineered drug-releasing implants in bone ex-vivo. Journal of Biomedical Materials Research Part A, 104(3), 714-725.
DOI Scopus35 WoS31 Europe PMC21
2015 Wluka, A., Teichtahl, A., Maulana, R., Liu, B., Wang, Y., Giles, G., . . . Cicuttini, F. (2015). Bone marrow lesions can be subtyped into groups with different clinical outcomes using two magnetic resonance imaging (MRI) sequences. Arthritis Research and Therapy, 17(1), 270-1-270-8.
DOI Scopus14 WoS13 Europe PMC10
2015 Rahman, S., Ormsby, R., Santos, A., Atkins, G., Findlay, D., & Losic, D. (2015). Nanoengineered drug-releasing aluminium wire implants: comparative investigation of nanopore geometry, drug release and osteoblast cell adhesion. RSC Advances, 5(92), 75004-75014.
DOI Scopus6 WoS6
2015 Ito, N., Wijenayaka, A., Prideaux, M., Kogawa, M., Ormsby, R., Evdokiou, A., . . . Atkins, G. (2015). Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli. Molecular and Cellular Endocrinology, 399(C), 208-218.
DOI Scopus149 WoS144 Europe PMC130
2015 Wijenayaka, A., Yang, D., Prideaux, M., Ito, N., Kogawa, M., Anderson, P., . . . Atkins, G. (2015). 1α,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion. Molecular and Cellular Endocrinology, 413(C), 157-167.
DOI Scopus44 WoS37 Europe PMC32
2015 Clarke, M., Russell, P., Findlay, D., Sastra, S., Anderson, P., Skinner, J., . . . Davey, R. (2015). A role for the Calcitonin respetor to limit bone loss during lactation in female mice by inhibiting osteocytic osteolysis. Endocrinology, 156(9), 3203-3214.
DOI Scopus48 WoS35 Europe PMC27
2015 Gulati, K., Santos, A., Findlay, D., & Losic, D. (2015). Optimizing anodization conditions for the growth of titania nanotubes on curved surfaces. Journal of Physical Chemistry C, 119(28), 16033-16045.
DOI Scopus110 WoS100
2015 Gulati, K., Kant, K., Findlay, D., & Losic, D. (2015). Periodically tailored titania nanotubes for enhanced drug loading and releasing performances. Journal of Materials Chemistry B, 3(12), 2553-2559.
DOI Scopus48 WoS45 Europe PMC25
2015 Rahman, S., Atkins, G., Findlay, D., & Losic, D. (2015). Nanoengineered drug releasing aluminium wire implants: a model study for localized bone therapy. Journal of Materials Chemistry B, 3(16), 3288-3296.
DOI Scopus14 WoS13 Europe PMC5
2015 Liapis, V., Labrinidis, A., Zinonos, I., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2015). Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. Cancer Letters, 357(1), 160-169.
DOI Scopus44 WoS41 Europe PMC40
2014 Zinonos, I., Labrinidis, A., Liapis, V., Hay, S., Panagopoulos, V., Denichilo, M., . . . Evdokiou, A. (2014). Doxorubicin overcomes resistance to drozitumab by antagonizing inhibitor of apoptosis proteins (IAPS). Anticancer Research, 34(12), 7007-7020.
Scopus9 WoS8 Europe PMC8
2014 Ito, N., Peña, A., Perano, S., Atkins, G., Findlay, D., & Couper, J. (2014). First Australian report of vitamin D-dependent rickets type I. Medical Journal of Australia, 201(7), 420-421.
DOI Scopus6 WoS4 Europe PMC3
2014 Prideaux, M., Wijenayaka, A., Kumarasinghe, D., Ormsby, R., Evdokiou, A., Findlay, D., & Atkins, G. (2014). SaOS2 osteosarcoma cells as an in vitro model for studying the transition of human osteoblasts to osteocytes. Calcified Tissue International, 95(2), 183-193.
DOI Scopus97 WoS96 Europe PMC76
2014 Zinonos, I., Luo, K., Labrinidis, A., Liapis, V., Hay, S., Panagopoulos, V., . . . Evdokiou, A. (2014). Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. International Journal of Oncology, 45(2), 532-540.
DOI Scopus20 WoS20 Europe PMC18
2014 Low, S., Bain, G., Findlay, D., Eng, K., & Perilli, E. (2014). External and internal bone micro-architecture in normal and Kienböck's lunates: A whole-bone micro-computed tomography study. Journal of Orthopaedic Research, 32(6), 826-833.
DOI Scopus27 WoS21 Europe PMC18
2014 Findlay, D. M., & Atkins, G. J. (2014). Osteoblast-chondrocyte interactions in osteoarthritis. Current Osteoporosis Reports, 12(1), 127-134.
DOI Scopus123 WoS115 Europe PMC103
2014 Stamenkov, R., Neale, S., Kane, T., Findlay, D., Taylor, D., & Howie, D. (2014). Cemented liner exchange with bone grafting halts the progression of periacetabular osteolysis. Journal of Arthroplasty, 29(4), 822-826.
DOI Scopus10 WoS7 Europe PMC5
2014 Ito, N., Findlay, D., & Atkins, G. (2014). Osteocyte communication with the kidney via the production of FGF23: Remote control of phosphate homeostasis. Clinical Reviews in Bone and Mineral Metabolism, 12(1), 44-58.
DOI Scopus9 WoS7
2013 Findlay, D. (2013). Long overlooked: the role of subchondral bone in osteoarthritis pathophysiology and pain. Medicographia, 35(2), 221-227.
2013 Callary, S., Thewlis, D., Rowlands, A., Findlay, D., & Solomon, L. (2013). Collecting a comprehensive evidence base to monitor fracture rehabilitation: a case study. World Journal of Orthopedics, 4(4), 259-266.
DOI Scopus5 WoS5 Europe PMC3
2013 Kogawa, M., Wijenayaka, A., Ormsby, R., Thomas, G., Anderson, P., Bonewald, L., . . . Atkins, G. (2013). Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. Journal of Bone and Mineral Research, 28(12), 2436-2448.
DOI Scopus141 WoS127 Europe PMC110
2013 Howie, D., Neale, S., Haynes, D., Holubowycz, O., McGee, M., Solomon, L., . . . Findlay, D. (2013). Periprosthetic osteolysis after total hip replacement: molecular pathology and clinical management. Inflammopharmacology, 21(6), 389-396.
DOI Scopus40 WoS35 Europe PMC27
2013 Kogawa, M., Hisatake, K., Atkins, G., Findlay, D., Enoki, Y., Sato, T., . . . Matsumoto, M. (2013). The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-kB ligand (RANKL)-induced Osteoclast differentiation. Journal of Biological Chemistry, 288(43), 31299-31312.
DOI Scopus20 WoS20 Europe PMC15
2013 Welldon, K., Findlay, D., Evdokiou, A., Ormsby, R., & Atkins, G. (2013). Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. Molecular and Cellular Endocrinology, 376(1), 85-92.
DOI Scopus28 WoS29 Europe PMC25
2013 Ito, N., Findlay, D., Anderson, P., Bonewald, L., & Atkins, G. (2013). Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D₃ (1,25D) on osteocyte like cells. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 183-186.
DOI Scopus52 WoS47 Europe PMC48
2013 Davey, R., & Findlay, D. (2013). Calcitonin: physiology or fantasy?. Journal of Bone and Mineral Research, 28(5), 973-979.
DOI Scopus79 WoS71 Europe PMC55
2013 Kogawa, M., Findlay, D., Anderson, P., & Atkins, G. (2013). Modulation of osteoclastic migration by metabolism of 25(OH)-vitamin D₃. Journal of Steroid Biochemistry and Molecular Biology, 136(1), 59-61.
DOI Scopus16 WoS13 Europe PMC9
2013 Kato, N., Matsumoto, M., Kogawa, M., Atkins, G., Findlay, D., Fujikawa, T., . . . Ogata, M. (2013). Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo. Journal of Neuroinflammation, 10(1), 1-13.
DOI Scopus49 WoS46 Europe PMC52
2012 Aw, M., Khalid, K., Gulati, K., Atkins, G., Pivonka, P., Findlay, D., & Losic, D. (2012). Characterization of drug-release kinetics in trabecular bone from titania nanotube implants. International Journal of Nanomedicine (online), 7, 4883-4892.
DOI Scopus56 WoS46 Europe PMC20
2012 Howie, D., Neale, S., Martin, W., Costi, K., Kane, T., Stamenkov, R., & Findlay, D. (2012). Progression of periacetabular osteolytic lesions. Journal of Bone and Joint Surgery-American Volume, 94(16), 1-6.
DOI Scopus24 WoS21 Europe PMC19
2012 Atkins, G., & Findlay, D. (2012). Osteocyte regulation of bone mineral: a little give and take. Osteoporosis International, 23(8), 2067-2079.
DOI Scopus137 WoS113 Europe PMC100
2012 Gulati, K., Aw, M., Findlay, D., & Losic, D. (2012). Local drug delivery to the bone by drug-releasing implants: perspectives of nano-engineered titania nanotube arrays. Therapeutic Delivery, 3(7), 857-873.
DOI Scopus114 WoS106 Europe PMC51
2012 Alias, E., Dharmapatni, A., Holding, C., Atkins, G., Findlay, D., Howie, D., . . . Haynes, D. (2012). Polyethylene particles stimulate expression of ITAM-related molecules in peri-implant tissues and when stimulating osteoclastogenesis in vitro. Acta Biomaterialia, 8(8), 3104-3112.
DOI Scopus21 WoS19 Europe PMC20
2012 Gulati, K., Ramakrishnan, S., Aw, M., Atkins, G., Findlay, D., & Losic, D. (2012). Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion. Acta Biomaterialia, 8(1), 449-456.
DOI Scopus287 WoS256 Europe PMC127
2011 Anderson, P., Atkins, G., Turner, A., Kogawa, M., Findlay, D., & Morris, H. (2011). Vitamin D metabolism within bone cells: Effects on bone structure and strength. Molecular and Cellular Endocrinology, 347(1-2 Sp Is), 42-47.
DOI Scopus56 WoS54 Europe PMC34
2011 Wijenayaka, A., Kogawa, M., Lim, H., Bonewald, L., Findlay, D., & Atkins, G. (2011). Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One, 6(10), e25900-1-e25900-9.
DOI Scopus440 WoS400 Europe PMC338
2011 Howie, D., Mc Gee, M., Callary, S., Carbone, A., Stamenkov, R., Bruce, W., & Findlay, D. (2011). A preclinical study of stem subsidence and graft incorporation after femoral impaction grafting using porous hydroxyapatite as a bone graft extender. Journal of Arthroplasty, 26(7), 1050-1056.
DOI Scopus6 WoS4 Europe PMC4
2011 Findlay, D., & Atkins, G. (2011). Relationship between serum RANKL and RANKL in bone. Osteoporosis International, 22(10), 2597-2602.
DOI Scopus65 WoS59 Europe PMC48
2011 Dharmapatni, A., Smith, M., Crotti, T., Holding, C., Vincent, C., Weedon, H., . . . Haynes, D. (2011). TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis. Arthritis Research & Therapy, 13(2), R51-1-R51-10.
DOI Scopus40 WoS36 Europe PMC34
2011 Chehade, M., Vakaci, I., Callary, S., Findlay, D., & Solomon, L. (2011). Differentially loaded radiostereometric analysis (DLRSA) in torsion adds essential information in diaphyseal bone healing: the example of a tibial osteotomy. Journal of Bioengineering & Biomedical Sciences, 2011, 1-5.
DOI
2011 Atkins, G., Haynes, D., Howie, D., & Findlay, D. (2011). Role of polyethylene particles in peri-prosthetic osteolysis: A review. World Journal of Orthopedics, 2(10), 93-101.
DOI Scopus52 WoS40 Europe PMC32
2011 Atkins, G., Rowe, P., Lim, H., Welldon, K., Ormsby, R., Wijenayaka, A., . . . Findlay, D. (2011). Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. Journal of Bone and Mineral Research, 26(7), 1425-1436.
DOI Scopus213 WoS194 Europe PMC169
2011 Zinonos, I., Labrinidis, A., Lee, M., Liapis, V., Hay, S., Ponomarev, V., . . . Evdokiou, A. (2011). Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo. Journal of Bone and Mineral Research, 26(3), 630-643.
DOI Scopus19 WoS19 Europe PMC19
2011 Turner, A., Tjahyono, F., Chiu, W., Skinner, J., Sawyer, R., Moore, A., . . . Davey, R. (2011). The role of the calcitonin receptor in protecting against induced hypercalcemia is mediated via its actions in osteoclasts to inhibit bone resorption. Bone, 48(2), 354-361.
DOI Scopus33 WoS31 Europe PMC21
2011 Findlay, D. M. (2011). DEBATE: IS SUBCHONDRAL BONE OR ARTICULAR CARTILAGE THE BEST TARGET FOR DMOAD DEVELOPMENT? BONE. OSTEOARTHRITIS AND CARTILAGE, 19, S4.
DOI
2010 Kogawa, M., Findlay, D., Anderson, P., Ormsby, R., Vincent, C., Morris, H., & Atkins, G. (2010). Osteoclastic metabolism of 25(OH)-vitamin D-3: A potential mechanism for optimization of bone resorption. Endocrinology, 151(10), 4613-4625.
DOI Scopus131 WoS111 Europe PMC88
2010 Findlay, D. (2010). If good things come from above, do bad things come from below?. Arthritis Research & Therapy, 12(3), 119-1-119-2.
DOI Scopus16 WoS15 Europe PMC14
2010 Labrinidis, A., Hay, S., Liapis, V., Findlay, D., & Evdokiou, A. (2010). Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model. International Journal of Cancer, 127(2), 345-354.
DOI Scopus29 WoS27 Europe PMC27
2010 Kogawa, M., Anderson, P., Findlay, D., Morris, H., & Atkins, G. (2010). The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. Journal of Steroid Biochemistry and Molecular Biology, 121(1-2 Sp Iss), 277-280.
DOI Scopus69 WoS55 Europe PMC42
2010 Stamenkov, R., Howie, D., Neale, S., Mc Gee, M., Taylor, D., & Findlay, D. (2010). Distribution of periacetabular osteolytic lesions varies according to component design. Journal of Arthroplasty, 25(6), 913-919.
DOI Scopus6 WoS8 Europe PMC8
2009 Zinonos, I., Labrinidis, A., Lee, M., Liapis, V., Hay, S., Ponomarev, V., . . . Evdokiou, A. (2009). Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer. Molecular Cancer Therapeutics, 8(10), 2969-2980.
DOI Scopus38 WoS39 Europe PMC35
2009 Atkins, G., Welldon, K., Wijenayaka, A., Bonewald, L., & Findlay, D. (2009). Vitamin K promotes mineralization, osteoblast-to-osteocyte transition, and an anticatabolic phenotype by y-carboxylation-dependent and -independent mechanisms. American Journal of Physiology-Cell Physiology, 297(6), C1358-C1367.
DOI Scopus110 WoS106 Europe PMC88
2009 Vincent, C., Findlay, D., Welldon, K., Wijenayaka, A., Zheng, T., Haynes, D., . . . Atkins, G. (2009). Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNF alpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. Journal of Bone and Mineral Research, 24(8), 1434-1449.
DOI Scopus160 WoS156 Europe PMC131
2009 Atkins, G., Welldon, K., Holding, C., Haynes, D., Howie, D., & Findlay, D. (2009). The induction of a catabolic phenotype in human primary osteoblasts and osteocytes by polyethylene particles. Biomaterials, 30(22), 3672-3681.
DOI Scopus92 WoS88 Europe PMC82
2009 Labrinidis, A., Hay, S., Liapis, V., Ponomarev, V., Findlay, D., & Evdokiou, A. (2009). Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model. Clinical Cancer Research, 15(10), 3451-3461.
DOI Scopus69 WoS63 Europe PMC58
2009 Dharmapatni, A., Smith, M., Findlay, D., Holding, C., Evdokiou, A., Ahern, M., . . . Haynes, D. (2009). Elevated expression of caspase-3 inhibitors, survivin and xIAP correlates with low levels of apoptosis in active rheumatoid synovium. Arthritis Research & Therapy, 11(1), R13:1-R13:11.
DOI Scopus54 WoS57 Europe PMC53
2009 Labrinidis, A., Diamond, P., Martin, S., Hay, S., Liapis, V., Zinonos, I., . . . Evdokiou, A. (2009). Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma. Clinical Cancer Research, 15(6), 1998-2009.
DOI Scopus33 WoS31 Europe PMC30
2009 Vincent, C., Kogawa, M., Findlay, D., & Atkins, G. (2009). The generation of osteoclasts from RAW 264.7 precursors in defined, serum-free conditions. Journal of Bone and Mineral Metabolism, 27(1), 114-119.
DOI Scopus57 WoS52 Europe PMC46
2009 Atkins, G., Welldon, K., Halbout, P., & Findlay, D. (2009). Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. Osteoporosis International, 20(4), 653-664.
DOI Scopus183 WoS167 Europe PMC131
2009 Hopwood, B., Tsykin, A., Findlay, D., & Fazzalari, N. (2009). Gene expression profile of the bone microenvironment in human fragility fracture bone. Bone, 44(1), 87-101.
DOI Scopus101 WoS98 Europe PMC88
2008 Davey, R., Turner, A., McManus, J., Chiu, W., Tjahyono, F., Moore, A., . . . Zajac, J. (2008). Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. Journal of Bone and Mineral Research, 23(8), 1182-1193.
DOI Scopus90 WoS76 Europe PMC54
2008 Findlay, D., Chehade, M., Tsangari, H., Neale, S., Hay, S., Hopwood, B., . . . Fazzalari, N. (2008). Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males. Arthritis Research & Therapy, 10(1), 1-9.
DOI Scopus27 WoS25 Europe PMC25
2008 Welldon, K., Atkins, G., Howie, D., & Finlay, D. (2008). Primary human osteoblasts grow into porous tantalum and maintain an osteoblastic phenotype. Journal of Biomedical Materials Research. Part A, 84A(3), 691-701.
DOI Scopus89 WoS77 Europe PMC48
2008 Labrinidis, A., Liapis, V., Thai, L., Atkins, G., Vincent, C., Hay, S., . . . Evdokiou, A. (2008). Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?. Blood, 111(11), 5411-5412.
DOI Scopus19 WoS15 Europe PMC10
2008 Fazzalari, N. L., Tsangari, H., Neale, S., Hay, S., Hopwood, B., Chehade, M., & Findlay, D. M. (2008). Relationship between bone RANKL MRNA levels and bone structural and turnover markers in male osteoarthritics. CALCIFIED TISSUE INTERNATIONAL, 82, S129.
2007 Atkins, G. J., Welldon, K. J., & Findlay, D. M. (2007). Strontium ranelate promotes an osteocyte-like phenotype from human primary osteoblasts ex vivo. CALCIFIED TISSUE INTERNATIONAL, 80, S71-S72.
2007 Atkins, G., Anderson, P., Findlay, D., Welldon, K., Vincent, C., Zannettino, A., . . . Morris, H. (2007). Metabolism of vitamin D₃ in human osteoblasts: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D₃. Bone, 40(6), 1517-1528.
DOI Scopus228 WoS201 Europe PMC173
2007 Anderson, P., Atkins, G., Findlay, D., O'Loughlin, P., Welldon, K., Vincent, C., & Morris, H. (2007). RNAi-mediated silencing of CYP27B1 abolishes 1,25(OH)₂D₃ synthesis and reduces osteocalcin and CYP24 mRNA expression in human osteosarcoma (HOS) cells. Journal of Steroid Biochemistry and Molecular Biology, 103(3-5 Sp Iss), 601-605.
DOI Scopus43 WoS35 Europe PMC28
2007 Tsangari, H., Findlay, D., & Fazzalari, N. (2007). Structural and remodeling indices in the cancellous bone of the proximal femur across adulthood. Bone, 40(1), 211-217.
DOI Scopus26 WoS26 Europe PMC22
2007 Howie, D., Neale, S., Stamenkov, R., Mc Gee, M., Taylor, D., & Findlay, D. (2007). Progression of acetabular periprosthetic osteolytic lesions measured with computed tomography. Journal of Bone and Joint Surgery-American Volume, 89A(8), 1818-1825.
DOI Scopus54 WoS49 Europe PMC43
2007 Hopwood, B., Tsykin, A., Findlay, D., & Fazzalari, N. (2007). Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-β/bone morphogenic protein signalling. Arthritis Research & Therapy, 9(5), WWW 1-WWW 21.
DOI Scopus174 WoS162 Europe PMC149
2007 Findlay, D. (2007). Vascular pathology and osteoarthritis. Rheumatology, 46(12), 1763-1768.
DOI Scopus252 WoS217 Europe PMC188
2007 Taylor, A., Dunne, M., Bennington, S., Ansell, S., Gardner, I., Norreys, P., . . . Nelmes, R. (2007). A route to the brightest possible neutron source?. Science, 315(5815), 1092-1095.
DOI Scopus66
2006 O'Neill, S., MacLennan, A., Bass, S., Diamond, T., Ebeling, P., Findlay, D., . . . Fiatarone-Singh, M. (2006). Wytyczne postępowania z osteoporozą omenopauzalną dla lekarzy rodzinnych. Lekarz Rodzinny, 4(104), 444-455.
2006 Thai, L., Labrinidis, A., Hay, S., Liapis, V., Bouralexis, S., Welldon, K., . . . Evdokiou, A. (2006). Apo21/tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model. Cancer Research, 66(10), 5363-5370.
DOI Scopus30 WoS27 Europe PMC23
2006 Findlay, D. (2006). Regulation of cell growth mediated by the calcitonin receptor. Cellular and Molecular Biology, 52(3), 3-8.
DOI Scopus8 WoS8 Europe PMC4
2006 Tsangari, H., Findlay, D., Zannettino, A., Pan, B., Kuliwaba, J., & Fazzalari, N. (2006). Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patients. Bone, 39(6), 1226-1235.
DOI Scopus19 WoS19 Europe PMC16
2006 Holding, C., Findlay, D., Stamenkov, R., Neale, S., Lucas, H., Dharmapatni, A., . . . Haynes, D. (2006). The correlation of RANK, RANKL and TNFα expression with bone loss volume and polyethylene wear debris around hip implants. Biomaterials, 27(30), 5212-5219.
DOI Scopus116 WoS107 Europe PMC88
2006 Atkins, G., Kostakis, P., Vincent, C., Farrugia, A., Houchins, J., Findlay, D., . . . Zannettino, A. (2006). RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. Journal of Bone and Mineral Research, 21(9), 1339-1349.
DOI Scopus116 WoS110 Europe PMC102
2006 Perper, S., Browning, B., Burkly, L., Weng, S., Gao, C., Giza, K., . . . Hess, H. (2006). TWEAK is a novel arthritogenic mediator. Journal of Immunology, 177(4), 2610-2620.
DOI Scopus145 WoS138 Europe PMC118
2006 Butler, L., Liapis, V., Bouralexis, S., Welldon, K., Hay, S., Thai, L., . . . Evdokiou, A. (2006). The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL. International Journal of Cancer, 119(4), 944-954.
DOI Scopus71 WoS65 Europe PMC53
2005 Findlay, D., & Haynes, D. (2005). Mechanisms of bone loss in rheumatoid arthritis. Modern Rheumatology, 15(4), 232-240.
DOI Scopus47 Europe PMC33
2005 Bouralexis, S., Findlay, D., & Evdokiou, A. (2005). Death to the bad buys: Targeting cancer via Apo2L/TRAIL. Apoptosis, 10(1), 35-51.
DOI Scopus114 WoS109 Europe PMC87
2005 Zannettino, A., Holding, C., Diamond, P., Atkins, G., Kostakis, P., Farrugia, A., . . . Haynes, D. (2005). Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor. Journal of Cellular Physiology, 204(2), 714-723.
DOI Scopus146 WoS145 Europe PMC117
2005 Atkins, G., Kostakis, P., Welldon, K., Vincent, C., Findlay, D., & Zannettino, A. (2005). Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Journal of Cellular Physiology, 203(3), 573-582.
DOI Scopus30 WoS30 Europe PMC30
2005 Kuliwaba, J., Fazzalari, N., & Findlay, D. (2005). Stability of RNA isolated from human trabecular bone at post-mortem and surgery. Biochimica et Biophysica Acta-Molecular Basis of Disease, 1740(1), 1-11.
DOI Scopus36 WoS33 Europe PMC28
2005 Hopwood, B., Gronthos, S., Kuliwaba, J., Robey, P., Findlay, D., & Fazzalari, N. (2005). Identification of differentially expressed genes between osteoarthritic and normal trabecular bone from the intertrochanteric region of the proximal femur using cDNA microarray analysis. Bone, 36(4), 635-644.
DOI Scopus21 WoS19 Europe PMC18
2005 Suva, L., Gaddy, D., Perrien, D., Thomas, R., & Findlay, D. (2005). Regulation of bone mass by mechanical loading: Microarchitecture and genetics. Current Osteoporosis Reports, 3(2), 46-51.
DOI Scopus52 Europe PMC40
2004 O'Neill, S., MacLennan, A., Diamond, T., Ebeling, P., Findlay, D., Flicker, L., . . . Fiatarone-Singh, M. (2004). Guidelines for the management of postmenopausal osteoporosis for GPs. Australian Family Physician, 33(11), 910-919.
Scopus36 Europe PMC20
2004 Findlay, D., & Sexton, P. (2004). Calcitonin. Growth Factors, 22(4), 217-224.
DOI Scopus55 WoS46 Europe PMC33
2004 Crotti, T., Smith, M., Findlay, D., Zreiqat, H., Ahern, M., Weedon, H., . . . Haynes, D. (2004). Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NF[kappa]B, RANK ligand and osteoprotegerin. Biomaterials, 25(4), 565-573.
DOI Scopus145 WoS131 Europe PMC118
2004 Mc Gee, M., Findlay, D., Howie, D., Carbone, A., Ward, P., Stamenkov, R., . . . Toth, C. (2004). The use of OP-1 in femoral impaction grafting in a sheep model. Journal of Orthopaedic Research, 22(5), 1008-1015.
DOI Scopus55 WoS49 Europe PMC40
2004 Davey, R., MacLean, H., McManus, J., Findlay, D., & Zajac, J. (2004). Genetically modified animal models as tools for studying bone and mineral metabolism. Journal of Bone and Mineral Research, 19(6), 882-892.
DOI Scopus33 WoS28 Europe PMC26
2004 Tsangari, H., Findlay, D., Kuliwaba, J., Atkins, G., & Fazzalari, N. (2004). Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone, 35(1), 334-342.
DOI Scopus57 WoS55 Europe PMC46
2004 Bouralexis, S., Clayer, M., Atkins, G., Labrinidis, A., Hay, S., Graves, S., . . . Evdokiou, A. (2004). Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin. International Journal of Oncology, 24(5), 1263-1270.
DOI Scopus14 WoS14 Europe PMC11
2004 Findlay, D., Welldon, K., Atkins, G., Howie, D., Zannettino, A., & Bobyn, D. (2004). The proliferation and phenotypic expression of human osteoblasts on tantalum metal. Biomaterials, 25(12), 2215-2227.
DOI Scopus195 WoS172 Europe PMC97
2004 Pan, B., To, L., Farrugia, A., Findlay, D., Green, J., Gronthos, S., . . . Zannettino, A. (2004). The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. Bone, 34(1), 112-123.
DOI Scopus105 WoS95 Europe PMC76
2004 Pan, B., Farrugia, A., To, L., Findlay, D., Green, J., Lynch, K., & Zannettino, A. (2004). The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). Journal of Bone and Mineral Research, 19(1), 147-154.
DOI Scopus149 WoS138 Europe PMC121
2004 Hu, Y., Zhou, H., Myers, D., Quinn, J., Atkins, G., Ly, C., . . . Ng, K. (2004). Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts. Journal of Bone and Mineral Research, 19(1), 89-99.
DOI Scopus45 WoS41 Europe PMC39
2003 Atkins, G., Kostakis, P., Pan, B., Farrugia, A., Gronthos, S., Evdokiou, A., . . . Zannettino, A. (2003). RANKL expression is related to the differentiation state of human osteoblasts. Journal of Bone and Mineral Research, 18(6), 1088-1098.
DOI Scopus221 WoS202 Europe PMC178
2003 Stamenkov, R., Howie, D., Taylor, J., Findlay, D., Mc Gee, M., Kourlis, G., . . . Burwell, M. (2003). Measurement of bone defects adjacent to acetabular components of hip replacement. Clinical Orthopaedics and Related Research, 412(412), 117-124.
DOI Scopus39 WoS31 Europe PMC20
2003 Farrugia, A., Atkins, G., To, L., Pan, B., Horvath, N., Kostakis, P., . . . Zannettino, A. (2003). Receptor activator of nuclear factor-kB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo. Cancer Research, 63(17), 5438-5445.
Scopus203 WoS190 Europe PMC156
2003 Evdokiou, A., Labrinidis, A., Bouralexis, S., Hay, S., & Findlay, D. (2003). Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis. Bone, 33(2), 216-228.
DOI Scopus76 WoS72 Europe PMC59
2003 Bouralexis, S., Findlay, D., Atkins, G., Labrinidis, A., Hay, S., & Evdokiou, A. (2003). Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. British Journal of Cancer, 89(1), 206-214.
DOI Scopus62 WoS60 Europe PMC45
2003 Pan, B., To, L., Farrugia, A., Kostakis, P., Atkins, G., Findlay, D., & Zannettino, A. (2003). Multiple myeloma-derived pro-inflammatory cytokines enhance osteoclastogenesis by increasing the number of RANKL-expressing STRO-1 positive osteoprogenitor cells. Blood, 102(11), 5207.
2002 Atkins, G., Bouralexis, S., Evdokiou, A., Hay, S., Labrinidis, A., Zannettino, A., . . . Findlay, D. (2002). Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis. Bone, 31(4), 448-456.
DOI Scopus60 WoS60 Europe PMC48
2002 Crotti, T., Smith, M., Weedon, H., Ahern, M., Findlay, D., Kraan, M., . . . Haynes, D. (2002). Receptor activator NFκB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. Annals of the Rheumatic Diseases, 61(12), 1047-1054.
DOI Scopus174 WoS157 Europe PMC132
2002 Findlay, D., Raggatt, L., Bouralexis, S., Hay, S., Atkins, G., & Evdokiou, A. (2002). Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism. Journal of Endocrinology, 175(3), 715-725.
DOI Scopus20 WoS15 Europe PMC11
2002 Evdokiou, A., Bouralexis, S., Atkins, G., Chai, F., Hay, S., Clayer, M., & Findlay, D. (2002). Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosis. International Journal of Cancer, 99(4), 491-504.
DOI Scopus132 WoS131 Europe PMC97
2002 O'Neill, S., Sambrook, P., Diamond, T., Ebeling, P., Ferris, L., Flicker, L., . . . Williamson, M. (2002). Guidelines for the treatment of postmenopausal osteoporosis for general practitioners. Australian Family Physician, 31(10), 921-928.
Scopus9 Europe PMC4
2002 Atkins, G., Haynes, D., Zannettino, A., Capone, M., Crotti, T., & Findlay, D. (2002). Haemopoietic cells influence stromal cell gene expression during human osteoclast development. Journal of Bone and Joint Surgery - British Volume, 84B(Suppl.3), 235.
2002 Atkins, G., Crotti, T., Loric, M., Findlay, D., Howie, D., Bain, G., & Haynes, D. (2002). Periprosthetic osteolysis is associated with wear particles stimulating factors that control osteoclast formation. Journal of Bone and Joint Surgery - British Volume, 84B(Suppl.3), 234.
2002 Atkins, G., Crotti, T., Loric, M., Findlay, D., Smith, M., & Haynes, D. (2002). Osteolysis in bone loss pathologies is associated with similar factors that control osteoclast formation. Asia Pacific Orthopaedic Association.. Journal of Bone and Joint Surgery - British Volume, 84B(Suppl.3), 234-235.
2002 O'Neill, S., Sambrook, P., Diamond, T., Ebeling, P., Ferris, L., Flicker, L., . . . Williamson, M. (2002). Guidelines for the treatment of postmenopausal osteoporosis for general practitioners.. Australian family physician, 31(10), 921-928.
Scopus8
2001 Crotti, T. N., Smith, M. D., Weedon, H., Capone, M., Holding, C., Findlay, D. M., & Haynes, D. R. (2001). Osteoprotegerin (OPG) and RANKL expression in tissues near bone in diseases of pathological bone loss: A comparison of rheumatoid arthritis, prosthetic joint failure and periodontal disease.. JOURNAL OF BONE AND MINERAL RESEARCH, 16, S227.
WoS1
2001 Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (2001). Gene expression in human cancellous bone is similar between skeletal sites.. JOURNAL OF BONE AND MINERAL RESEARCH, 16, S327.
2001 Haynes, D., Crotti, T., Loric, M., Bain, G., Atkins, G., & Findlay, D. (2001). Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint. Rheumatology, 40(6), 623-630.
DOI Scopus188 WoS168 Europe PMC138
2001 Haynes, D., Crotti, T., Potter, A., Loric, M., Atkins, G., Howie, D., & Findlay, D. (2001). The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. Journal of Bone and Joint Surgery-British Volume, 83B(6), 902-911.
DOI Scopus170 WoS142 Europe PMC108
2001 Fazzalari, N., Kuliwaba, J., Atkins, G., Forwood, M., & Findlay, D. (2001). The ratio of messenger RNA levels of receptor activator of nuclear factor kB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis. Journal of Bone and Mineral Research, 16(6), 1015-1027.
DOI Scopus120 WoS104 Europe PMC92
2001 Evdokiou, A., Atkins, G., Bouralexis, S., Hay, S., Raggatt, L., Cowled, P., . . . Findlay, D. (2001). Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone. International Journal of Oncology, 19(3), 625-632.
DOI Scopus23 WoS22 Europe PMC18
2001 Wada, S., Yasuda, S., Nagai, T., Maeda, T., Kitahama, S., Suda, S., . . . Katayama, S. (2001). Regulation of calcitonin receptor by glucocorticoid in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kB ligand and macrophage colony-stimulating factor. Endocrinology, 142(4), 1471-1478.
DOI Scopus23 WoS16 Europe PMC12
2001 Atkins, G., Bouralexis, S., Haynes, D., Graves, S., Geary, S., Evdokiou, A., . . . Findlay, D. (2001). Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone, 28(4), 370-377.
DOI Scopus86 WoS83 Europe PMC68
2001 Fazzalari, N., Kuliwaba, J., Atkins, G., Forwood, M., & Findlay, D. (2001). Osteoclast differentiation factor is dominant in controlling the extent of bone resorption. Bone, 28(5), S160.
DOI
2001 Findlay, D., Bouralexis, S., Atkins, G., Chai, F., Hay, S., Clayer, M., & Evdokiou, A. (2001). Protection of normal human bone cells from Apo2L/TRAIL and chemotherapeutic drug combination-induced apoptosis. Bone, 28(5), S137.
DOI
2001 Atkins, G., Evdokiou, A., Bouralexis, S., Chai, F., Hay, S., Clayer, M., & Findlay, D. (2001). Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosis. Bone, 28(5), S82.
2001 Clayer, M., Bouralexis, S., Evdokiou, A., Hay, S., Atkins, G., & Findlay, D. (2001). Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAIL. Journal of Orthopaedic Surgery, 9(2), 19-22.
DOI Scopus18 Europe PMC15
2001 Wada, S., Yasuda, S., Nagai, T., Maeda, T., Kitahama, S., Suda, S., . . . Katayama, S. (2001). Regulation of Calcitonin Receptor by Glucocorticoid in Human Osteoclast-Like Cells Prepared in VitroUsing Receptor Activator of Nuclear Factor-κB Ligand and Macrophage Colony-Stimulating Factor.. Endocrinology, 142(4), 1471-1478.
DOI
2000 Lawrence Riggs, B., Baron, R., Boyle, W. J., John Martin, T., Suda, T., Yasuda, H., . . . Zambonin-Zallone, A. M. (2000). Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption. Bone, 27(6), 761-764.
DOI Scopus20 Europe PMC10
2000 Atkins, G., Haynes, D., Graves, S., Evdokiou, A., Hay, S., Bouralexis, S., & Findlay, D. (2000). Expression of osteoclast differentiation signals by stromal elements of giant cell tumors. Journal of Bone and Mineral Research, 15(4), 640-649.
DOI Scopus167 WoS167 Europe PMC131
2000 Kitahama, S., Gibson, M., Hatzinikolas, G., Hay, S., Kuliwaba, J., Evdokiou, A., . . . Findlay, D. (2000). Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells. Bone, 27(1), 61-67.
DOI Scopus59 WoS56 Europe PMC45
2000 Findlay, D., Atkins, G., Forwood, M., Kuliwaba, J., & Fazzalari, N. (2000). Enhanced expression of osteocalcin mRNA in human osteoarthritic trabecular bone of the proximal femur is associated with decreased expression of interleukin-6 and interleukin-11 mRNA. Journal of Bone and Mineral Research, 15(2), 332-341.
DOI Scopus47 WoS44 Europe PMC38
2000 Raggatt, L., Evdokiou, A., & Findlay, D. (2000). Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert-negative, but not the insert-positive isoform of the human calcitonin receptor. Journal of Endocrinology, 167(1), 93-105.
DOI Scopus32 WoS26 Europe PMC15
2000 Evdokiou, A., Raggatt, L., Sakai, T., & Findlay, D. (2000). Identification of a novel calcitonin-response element in the promoter of the human p21 WAF1/CIP1 gene. Journal of Molecular Endocrinology, 25(2), 195-206.
DOI Scopus12 WoS12 Europe PMC8
2000 Atkins, G., Haynes, D., Geary, S., Loric, M., Crotti, T., & Findlay, D. (2000). Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation. Bone, 26(6), 653-661.
DOI Scopus69 WoS65 Europe PMC51
2000 Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (2000). A molecular histomorphometric study of osteoarthritic cancellous bone. JOURNAL OF BONE AND MINERAL RESEARCH, 15(4), 811.
2000 Findlay, D. M., Bouralexis, S., Atkins, G. J., Hedi, L., Hay, S., & Evdokiou, A. (2000). TRAIL-induced apoptosis of osteogenic sarcoma and breast cancer cells.. JOURNAL OF BONE AND MINERAL RESEARCH, 15, S352.
1999 Atkins, G. J., Haynes, D. R., Graves, S. E., Evdokiou, A., Hay, S., Bouralexis, S., . . . Findlay, D. M. (1999). Expression of osteoclast differentiation signals by stromal elements of giant cell tumours.. JOURNAL OF BONE AND MINERAL RESEARCH, 14, S176.
WoS1
1999 Raggatt, L. J., Evdokiou, A., & Findlay, D. M. (1999). Activation of the insert negative human calcitonin receptor: Phosphorylation of MAP kinase and inhibition of cellular proliferation.. JOURNAL OF BONE AND MINERAL RESEARCH, 14, S319.
1999 Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (1999). Bone remodelling in osteoarthritic cancellous bone a molecular histomorphometric study.. JOURNAL OF BONE AND MINERAL RESEARCH, 14, S464.
1999 Sexton, P. M., Findlay, D. M., & Martin, T. J. (1999). Calcitonin. Current Medicinal Chemistry, 6(11), 1067-1093.
DOI Scopus183 WoS158 Europe PMC92
1999 Haynes, D., Atkins, G., Loric, M., Crotti, T., Geary, S., & Findlay, D. (1999). Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation. Bone, 25(3), 269-278.
DOI Scopus40 WoS34 Europe PMC28
1999 Puche, R. C., Thomas, D. M., Udagawa, N., Hards, D. K., Quinn, J. M. W., Moseley, J. M., . . . Best, J. D. (1999). Letters to the editor (multiple letters).. Bone, 25(2), 251.
DOI
1999 Evdokiou, A., Raggatt, L., Findlay, D., & Atkins, G. (1999). Calcitonin Receptor-Mediated Growth Suppression of HEK-293 Cells is Accompanied by Induction of p21 WAF1/CIP1 and G2/M Arrest. Molecular Endocrinology, 13(10), 1738-1750.
DOI Scopus38 WoS34 Europe PMC23
1998 Thomas, D., Udagawa, N., Hards, D., Quinn, J., Moseley, J., Findlay, D., & Best, J. (1998). Insulin receptor expression in primary and cultured osteoclast-like cells. Bone, 23(3), 181-186.
DOI Scopus86 Europe PMC77
1998 Celic, S., Katayama, Y., Chilco, P., Martin, T., & Findlay, D. (1998). Type 1 collagen influence on gene expression in UMR106-06 osteoblast-like cells is inhibited by genistein. Journal of Endocrinology, 158(3), 377-388.
DOI Scopus31 WoS27 Europe PMC20
1998 Katayama, Y., House, C., Udagawa, N., Kazama, J., McFarland, R., Martin, T., & Findlay, D. (1998). Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts. Journal of Cellular Physiology, 176(1), 179-187.
DOI Scopus52 Europe PMC48
1998 Evdokiou, A., Raggatt, L., Atkins, G. J., & Findlay, D. M. (1998). Growth inhibition by calcitonin of HEK293 cells is accompanied by induction of p21/WAF1/CIP1 and G2/M arrest. MOLECULAR BIOLOGY OF THE CELL, 9, 484A.
1997 Katayama, Y., Soulis, T., Cooper, M. E., Seeman, E., Nagata, N., Martin, T. J., & Findlay, D. M. (1997). Aminoguanidine treatment increases bone mineral density in STZ induced diabetic rats.. DIABETOLOGIA, 40, 2289.
1997 Katayama, Y., Soulis, T., Cooper, M. E., Seeman, E., Nagata, N., Martin, T. J., & Findlay, D. M. (1997). Aminoguanidine treatment increases bone mineral density in streptozotocin (STZ)-induced diabetic rats: Possible role of age formation.. JOURNAL OF BONE AND MINERAL RESEARCH, 12, S650.
1997 Suva, L. J., Flannery, M. S., Caulfield, M. P., Findlay, D. M., Jüppner, H., Goldring, S. R., . . . Chorev, M. (1997). Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor. Journal of Pharmacology and Experimental Therapeutics, 283(2), 876-884.
DOI Scopus18 Europe PMC11
1997 Gillespie, M., Thomas, R., Pu, Z. Y., Zhou, H., & Findlay, D. (1997). Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers. International Journal of Cancer, 73(6), 812-815.
DOI Scopus92 Europe PMC65
1997 Findlay, D., & Martin, T. (1997). Receptors of Calciotropic Hormones. Hormone and Metabolic Research, 29(3), 128-134.
DOI Scopus15 Europe PMC9
1997 Findlay, D. (1997). Receptor regulation - food for thought. European Journal of Endocrinology, 137(3), 218-219.
DOI
1997 Katayama, Y., Celic, S., Nagata, N., Martin, T., & Findlay, D. (1997). Nonenzymatic Glycation of Type 1 Collagen Modifies Interaction With UMR 201-10B Preosteoblastic Cells. Bone, 21(1), 237-242.
DOI Scopus28 Europe PMC14
1997 Wada, S., Udagawa, N., Akatsu, T., Nagata, N., Martin, T., & Findlay, D. (1997). Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts. Endocrinology, 138(2), 521-529.
DOI Scopus50 Europe PMC26
1996 Traianedes, K., Martin, T., & Findlay, D. (1996). Regulation of osteopontin expression by type 1 collagen in preosteoblastic UMR201 cells. Connective Tissue Research, 34(1), 63-74.
DOI Scopus10 Europe PMC8
1996 Ikegame, M., Rakopoulos, M., Martin, T., Moseley, J., & Findlay, D. (1996). Effects of Continuous Calcitonin Treatment on Osteoclast-like Cell Development and Clacitonin Receptor Expression in Mouse Bone Marrow Cultures. Bone and Mineral Research, 11(4), 456-465.
DOI Scopus42 Europe PMC16
1996 Udagawa, N., Chan, J., Wada, S., & Findlay, D. (1996). c-fos Antisense DNA Inhibits Proliferation of Osteoclast Progenitors in Osteoclast Developments but not Macrophage Differentiation In Vitro. Bone, 18(6), 511-516.
DOI Scopus19 Europe PMC12
1996 Celic, S., Chilco, P., Zajac, J., Martin, T., & Findlay, D. (1996). A Type 1 collagen substrate increases PTH/PTHrP receptor MRNA expression and suppresses PTHrP mRNA expression in UMR106-06 osteoblast -like cells. Journal of Endocrinology, 150(2), 299-308.
DOI Scopus19 Europe PMC9
1996 Wada, S., Udagawa, N., Nagata, N., Martin, T., & Findlay, D. (1996). Physiological Levels of Calcitonin Regulate the Mouse Osteoclast Calcitonin Receptor by a Protein Kinase A-Mediated Mechanism. Endocrinology, 137(1), 312-320.
DOI Scopus50 Europe PMC24
1996 Findlay, D., Houssami, S., Christopoulos, G., & Sexton, P. (1996). Homologous Regulation of the Rat C1a Calcitonin Receptor (CTR) in Nonosteoclastic Cells is Independent of CTR Messenger Ribonucleic Acid Changes and Cyclis Adenosine 3', 5' -Monophospate-Dependent Protein Kinase Activation. Endocrinology, 137(11), 4576-4585.
DOI Scopus10 Europe PMC5
1996 Wada, S., Udagawa, N., Nagata, N., Martin, T., & Findlay, D. (1996). Calcitonin Receptor Down-Regulation Relates to Calcitonin Resistance in Mature Mouse Osteoclasts. Endocrinology, 137(3), 1042-1048.
DOI Scopus44 Europe PMC21
1995 Southey, M. C., Findlay, D. M., & Kemp, B. E. (1995). Regulation of membrane-associated tyrosine phosphatases in UMR 106.06 osteoblast-like cells. Biochemical Journal, 305(2), 485-490.
DOI Scopus19 Europe PMC17
1995 Findlay, D. M., Houssami, S., Sexton, P. M., Brady, C. L., Martin, T. J., & Myers, D. E. (1995). Calcium inflow in cells transfected with cloned rat and porcine calcitonin receptors. BBA - Molecular Cell Research, 1265(2-3), 213-219.
DOI Scopus7 Europe PMC4
1995 Rakopoulos, M., Ikegame, M., Findlay, D. M., Martin, T. J., & Moseley, J. M. (1995). Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA. Bone, 17(5), 447-453.
DOI Scopus39 Europe PMC21
1995 Manji, S. S., Zhou, H., Findlay, D. M., Martin, T. J., & Ng, K. W. (1995). Tumor necrosis factor α facilitates nuclear actions of retinoic acid to regulate expression of the alkaline phosphatase gene in preosteoblasts. Journal of Biological Chemistry, 270(15), 8958-8962.
DOI Scopus13 Europe PMC11
1995 Moore, E. E., Kuestner, R. E., Stroop, S. D., Grant, F. J., Matthewes, S. L., Brady, C. L., . . . Findlay, D. M. (1995). Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. Molecular Endocrinology, 9(8), 959-968.
DOI Scopus106 Europe PMC63
1995 Wada, S., Martin, T. J., & Findlay, D. M. (1995). Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells. Endocrinology, 136(6), 2611-2621.
DOI Scopus57 Europe PMC30
1995 Ikegame, M., Rakopoulos, M., Zhou, H., Houssami, S., Martin, J. T., Moseley, J. M., & Findlay, D. M. (1995). Calcitonin receptor isoforms in mouse and rat osteoclasts. Journal of Bone and Mineral Research, 10(1), 59-65.
DOI Scopus59 Europe PMC34
1995 Traianedes, K., Findlay, D. M., Martin, T. J., & Gillespie, M. T. (1995). Modulation of the signal recognition particle 54-kDa subunit (SRP54) in rat preosteoblasts by the extracellular matrix. Journal of Biological Chemistry, 270(36), 20891-20894.
DOI Scopus10 Europe PMC8
1995 Houssami, S., Findlay, D. M., Brady, C. L., Martin, T. J., Epand, R. M., Moore, E. E., . . . Sexton, P. M. (1995). Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation. Molecular Pharmacology, 47(4), 798-809.
DOI Scopus51 Europe PMC26
1995 Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T., Wada, S., Findlay, D. M., . . . Suda, T. (1995). Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. Journal of Experimental Medicine, 182(5), 1461-1468.
DOI Scopus373 Europe PMC279
1994 Sexton, P. M., Houssami, S., Brady, C. L., Myers, D. E., & Findlay, D. M. (1994). Amylin is an agonist of the renal porcine calcitonin receptor. Endocrinology, 134(5), 2103-2107.
DOI Scopus28 Europe PMC13
1994 Houssami, S., Findlay, D. M., Hilton, J. M., O'Keeffe, L. M., Martin, T. J., & Sexton, P. M. (1994). Heterogeneity in ligand recognition of calcitonin receptors. Endocrine, 2(2), 127-134.
Scopus16
1994 Findlay, D. M., Houssami, S., Lin, H. Y., Myers, D. E., Brady, C. L., Darcy, P. K., . . . Sexton, P. M. (1994). Truncation of the porcine calcitonin receptor cytoplasmic tail inhibits internalization and signal transduction but increases receptor affinity. Molecular Endocrinology, 8(12), 1691-1700.
DOI Scopus43 Europe PMC28
1994 Houssami, S., Findlay, D. M., Brady, C. L., Myers, D. E., Martin, T. J., & Sexton, P. M. (1994). Isoforms of the rat calcitonin receptor: Consequences for ligand binding and signal transduction. Endocrinology, 135(1), 183-190.
DOI Scopus94 Europe PMC62
1994 Zhou, H., Manji, S. S., Findlay, D. M., Martin, T. J., Heath, J. K., & Ng, K. W. (1994). Novel action of retinoic acid: Stabilization of newly synthesized alkaline phosphatase transcripts. Journal of Biological Chemistry, 269(35), 22433-22439.
DOI Scopus54 Europe PMC35
1994 Kuestner, R. E., Elrod, R. D., Grant, F. J., Hagen, F. S., Kuijper, J. L., Matthewes, S. L., . . . Moore, E. E. (1994). Cloning and characterization of an abundant subtype of the human calcitonin receptor. Molecular Pharmacology, 46(2), 246-255.
DOI Scopus156 Europe PMC83
1993 Ikeda, K., Michelangeli, V. P., Martin, T. J., & Findlay, D. M. (1993). Type I collagen substrate increases calcitonin and parathyroid hormone receptor‐mediated signal transduction in UMR 106–06 osteoblast‐like cells. Journal of Cellular Physiology, 156(1), 130-137.
DOI Scopus27 Europe PMC20
1993 Traianedes, K., Ng, K. W., Martin, T. J., & Findlay, D. M. (1993). Cell substratum modulates responses of preosteoblasts to retinoic acid. Journal of Cellular Physiology, 157(2), 243-252.
DOI Scopus32 Europe PMC21
1993 Sexton, P. M., Houssami, S., Hilton, J. M., O'Keeffe, L. M., Center, R. J., Gillespie, M. T., . . . Findlay, D. M. (1993). Identification of brain isoforms of the rat calcitonin receptor. Molecular Endocrinology, 7(6), 815-821.
DOI Scopus144 Europe PMC75
1993 Zhou, H., Hammonds, R. G., Findlay, D. M., Martin, T. J., & Ng, K. W. (1993). Differential effects of transforming growth factor‐β1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts. Journal of Cellular Physiology, 155(1), 112-119.
DOI Scopus55 Europe PMC42
1992 Schneider, H. G., Michelangeli, V. P., Frampton, R. J., Grogan, J. L., Ikeda, K., Martin, T. J., & Findlay, D. M. (1992). Transforming growth factor-β modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells. Endocrinology, 131(3), 1383-1389.
DOI Scopus45 Europe PMC29
1991 McQuillan, D. J., Findlay, D. M., Hocking, A. M., Yanagishita, M., Midura, R. J., & Hascall, V. C. (1991). Proteoglycans synthesized by an osteoblast-like cell line (UMR 106-01). Biochemical Journal, 277(1), 199-206.
DOI Scopus28 Europe PMC25
1991 Zhou, H., Hammonds, G. R., Findlay, D. M., Fuller, P. J., Martin, J. T., & Ng, K. W. (1991). Retinoic acid modulation of mrna levels in malignant, nontransformed, and immortalized osteoblasts. Journal of Bone and Mineral Research, 6(7), 767-777.
DOI Scopus77 Europe PMC51
1991 Kurokawa, M., Michelangeli, V. P., & Findlay, D. M. (1991). Induction of calcitonin receptor expression by glucocorticoids in T47D human breast cancer cells. Journal of Endocrinology, 130(2), 321-326.
DOI Scopus19 Europe PMC11
1991 Schneider, H. G., Allan, E. H., Moseley, J. M., Martin, T. J., & Findlay, D. M. (1991). Specific down-regulation of parathyroid hormone (PTH) receptors and responses to PTH by tumour necrosis factor α and retinoic acid in UMR 106-06 osteoblast-like osteosarcoma cells. Biochemical Journal, 280(2), 451-457.
DOI Scopus46 Europe PMC25
1991 Sexton, P. M., Schneider, H. G., D'Santos, C. S., Mendelsohn, F. A. O., Kemp, B. E., Moseley, J. M., . . . Findlay, D. M. (1991). Reversible calcitonin binding to solubilized sheep brain binding sites. Biochemical Journal, 273(1), 179-184.
DOI Scopus15 Europe PMC9
1990 Thiebaud, D., Ng, K. W., Findlay, D. M., Harker, M., & Martin, T. J. (1990). Insulinlike growth factor 1 regulates mRNA levels of osteonectin and pro‐α1(I)‐collagen in clonal preosteoblastic calvarial cells. Journal of Bone and Mineral Research, 5(7), 761-767.
DOI Scopus28 Europe PMC23
1989 Ng, K. W., Manji, S. S., Young, M. F., & Findlay, D. M. (1989). Opposing Influences of Glucocorticoid and Retinoic Acid on Transcriptional Control in Preosteoblasts. Molecular Endocrinology, 3(12), 2079-2085.
DOI Scopus61 Europe PMC47
1989 Findlay, D. M., Michelangeli, V. P., & Robinson, P. J. (1989). Protein kinase-c-induced down-regulation of calcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN Cells. Endocrinology, 125(5), 2656-2663.
DOI Scopus27 Europe PMC21
1989 Young, M. F., Findlay, D. M., Dominguez, P., Burbelo, P. D., McQuillan, C., Kopp, J. B., . . . Termine, J. D. (1989). Osteonectin promoter. DNA sequence analysis and S1 endonuclease site potentially associated with transcriptional control in bone cells. Journal of Biological Chemistry, 264(1), 450-456.
DOI Scopus54 Europe PMC40
1988 Findlay, D. M., Fisher, L. W., McQuillan, C. I., Termine, J. D., & Young, M. F. (1988). Isolation of the Osteonectin Gene: Evidence That a Variable Region of the Osteonectin Molecule Is Encoded within One Exon. Biochemistry, 27(5), 1483-1489.
DOI Scopus30 Europe PMC27
1987 Moseley, J. M., Findlay, D. M., Gorman, J. J., & Martin, T. J. (1987). Photoaffinity labeling of the calcitonin receptor. Pharmacology and Therapeutics, 34(1), 51-58.
DOI Scopus1 Europe PMC2
1986 Cosolo, W., Christophidis, N., Drummer, O. H., & Findlay, D. M. (1986). STUDIES ON THE CYTOTOXICITY OF PENICILLAMINE IN A RAT OSTEOGENIC SARCOMA. Clinical and Experimental Pharmacology and Physiology, 13(10), 737-743.
DOI Scopus1
1986 Michelangeli, V. P., Findlay, D. M., Fletcher, A., & Martin, T. J. (1986). Calcitonin gene-related peptide (CGRP) acts independently of calcitonin on cyclic AMP formation in clonal osteogenic sarcoma cells (UMR 106-01). Calcified Tissue International, 39(1), 44-48.
DOI Scopus44 Europe PMC29
1986 Findlay, D. M., & Martin, T. J. (1986). Kinetics of calcitonin receptor internalization in lung cancer (BEN) and osteogenic sarcoma (UMR 106–06) cells. Journal of Bone and Mineral Research, 1(3), 277-283.
DOI Scopus28 Europe PMC14
1985 Findlay, D. M., Michelangeli, V. P., Martin, T. J., Orlowski, R. C., & Seyler, J. K. (1985). Conformational requirements for activity of salmon calcitonin. Endocrinology, 117(3), 801-805.
DOI Scopus23 Europe PMC9
1985 Forrest, S. M., Ng, K. W., Findlay, D. M., Michelangeli, V. P., Livesey, S. A., Partridge, N. C., . . . Martin, T. J. (1985). Characterization of an osteoblast-like clonal cell line which responds to both parathyroid hormone and calcitonin. Calcified Tissue International, 37(1), 51-56.
DOI Scopus174 Europe PMC122
1984 Findlay, D. M., & Martin, T. J. (1984). Relationship between internalization and calcitonin induced receptor loss in T 47D cells. Endocrinology, 115(1), 78-83.
DOI Scopus34 Europe PMC23
1983 Michelangeli, V. P., Findlay, D. M., Moseley, J. M., & Martin, T. J. (1983). Mechanisms of calcitonin induction of prolonged activation of adenylate cyclase in human cancer cells. Journal of Cyclic Nucleotide and Protein Phosphorylation Research, 9(2), 129-142.
Scopus28 Europe PMC11
1983 Findlay, D. M., Michelangeli, V. P., Orlowski, R. C., & Martin, T. J. (1983). Biological activities and receptor interactions of des-leu16 salmon and des-phe16 human calcitonin. Endocrinology, 112(4), 1288-1291.
DOI Scopus30 Europe PMC26
1983 Moseley, J. M., Findlay, D. M., Gorman, J. J., Michelangeli, V. P., & Martin, T. J. (1983). The calcitonin receptor on T 47D breast cancer cells. Evidence for glycosylation. Biochemical Journal, 212(3), 609-616.
DOI Scopus17 Europe PMC16
1982 Frampton, R. J., Suva, L. J., Eisman, J. A., Findlay, D. M., Moseley, J. M., Martin, T. J., & Moore, G. E. (1982). Presence of 1,25-Dihydroxyvitamin D3 Receptors in Established Human Cancer Cell Lines in Culture. Cancer Research, 42(3), 1116-1119.
Scopus148 Europe PMC77
1982 Findlay, D. M., Ng, K. W., Niall, M., & Martin, T. J. (1982). Processing of calcitonin and epidermal growth factor after binding to receptors in human breast cancer cells (T 47D). Biochemical Journal, 206(2), 343-350.
DOI Scopus30 Europe PMC17
1982 Moseley, J. M., Findlay, D. M., & Martin, T. J. (1982). Covalent cross-linking of a photoactive derivative of calcitonin to human breast cancer cell receptors. Journal of Biological Chemistry, 257(10), 5846-5851.
DOI Scopus24 Europe PMC24
1982 Moseley, J. M., Findlay, D. M., Martin, T. J., & Gorman, J. J. (1982). A biological active photoaffinity probe used in identification of the calcitonin receptor. Clinical and Experimental Pharmacology and Physiology, 9(5), No.110.
1981 Findlay, D. M., Michelangeli, V. P., Moseley, J. M., & Martin, T. J. (1981). Calcitonin binding and degradation by two cultured human breast cancer cell lines (MCF 7 and T 47D). Biochemical Journal, 196(2), 513-520.
DOI Scopus43 Europe PMC31
1981 Findlay, D. M., De Luise, M., Michelangeli, V. P., & Martin, T. J. (1981). Independent down-regulation of insulin and calcitonin receptors on a human tumour cell line. Journal of Endocrinology, 88(2), 271-281.
DOI Scopus25 Europe PMC17
1981 Lamp, S. J., Findlay, D. M., & Moseley, J. M. (1981). Calcitonin responsive adenylate cyclase in human breast cancer cells. Clinical and Experimental Pharmacology and Physiology, 8(4), 397.
1981 Lamp, S. J., Findlay, D. M., Moseley, J. M., & Martin, T. J. (1981). Calcitonin induction of a persistent activated state of adenylate cyclase in human breast cancer cells (T 47D). Journal of Biological Chemistry, 256(23), 12269-12274.
DOI Scopus67 Europe PMC42
1980 Martin, T. J., Findlay, D. M., MacIntyre, I., Eisman, J. A., Michelangeli, V. P., Moseley, J. M., & Partridge, N. C. (1980). Calcitonin receptors in a cloned human breast cancer cell line (MCF 7). Topics in Catalysis, 96(1), 150-156.
DOI Scopus41 Europe PMC34
1980 Findlay, D. M., deLuise, M., Michelangeli, V. P., Martin, T. J., & Ellison, M. (1980). Properties of a calcitonin receptor and adenylate cyclase in ben cells, A human cancer cell line. Cancer Research, 40(4), 1311-1317.
Scopus71 Europe PMC58
1980 Findlay, D. M., Micneiangell, V. P., Eisman, J. A., Framptor, R. J., Moseley, J. M., Lain, M., . . . Whitehead, R. (1980). Calcitonin and 1,25-Dihydroxyvitamin D3 Receptors in Human Breast Cancer Cell Lines. Cancer Research, 40(12), 4764-4767.
Scopus107 Europe PMC76
1979 Dudley, F. J., Alford, F. P., Chisholm, D. J., & Findlay, D. M. (1979). Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: Paired studies of pre- and post-shunted subjects. Gut, 20(10), 817-824.
DOI Scopus27 Europe PMC24
1979 ALFORD, F. P., DUDLEY, F. J., CHISHOLM, D. J., & FINDLAY, D. M. (1979). GLUCAGON METABOLISM IN NORMAL SUBJECTS AND IN CIRRHOTIC PATIENTS BEFORE AND AFTER PORTASYSTEMIC VENOUS SHUNT SURGERY. Clinical Endocrinology, 11(4), 413-424.
DOI Scopus19 Europe PMC11
1979 Findlay, D. M., Omond, S., Alford, F. P., & Chisholm, D. J. (1979). Hyperglycemia and glucagon suppression: Possible importance of the vagus and enteric humoral factors. Journal of Clinical Endocrinology and Metabolism, 48(1), 13-16.
DOI Scopus10 Europe PMC4
1978 Chisholm, D. J., Alford, F. P., Harewood, M. S., Findlay, D. M., & Gray, B. N. (1978). Nature and biologic activity of "extrapancreatic glucagon": Studies in pancreatectomized cats. Metabolism, 27(3), 261-273.
DOI Scopus11 Europe PMC11
1977 PERRY‐KEENE, D. A., ALFORD., F. P., CHISHOLM., D. J., FINDLAY., D. M., LARKINS, R. G., & MARTIN, F. I. R. (1977). GLUCAGON AND DIABETES: I. THE FAILURE OF HYPERGLUCAGONAEMIA TO INFLUENCE THE RESPONSE OF ESTABLISHED DIABETIC KETOACIDOSIS TO THERAPY. Clinical Endocrinology, 6(6), 417-423.
DOI Scopus4 Europe PMC1

Year Citation
2020 Findlay, D. M. (2020). Osteoblasts in human skeletal diseases. In Encyclopedia of Bone Biology (pp. 499-512). Elsevier.
DOI
2019 Martin, T. J., Moseley, J. M., Findlay, D. M., & Michelangeli, V. P. (2019). CALCITONIN PRODUCTION AND CALCITONIN RECEPTORS IN HUMAN CANCERS. In Hormones in Normal and Abnormal Human Tissues Volume 1 (Vol. 1, pp. 429-457). De Gruyter.
DOI Scopus5
2018 Findlay, D. (2018). Biology of bone and the interaction of bone with other organ systems. In P. Pivonka (Ed.), Multiscale Mechanobiologyof Bone Remodelingand Adaptation (Vol. 578, pp. 259-287). Switzerland: Springer.
DOI Scopus3
2018 Anderson, P., Atkins, G., Morris, H., & Findlay, D. (2018). Vitamin D Activities in Osteocytes. In D. Feldman, J. W. Pike, R. Bouillon, E. Giovannucci, D. Goltzman, & M. Hewison (Eds.), Vitamin D: Fourth Edition (Vol. 1, 4th ed., pp. 319-327). London, United Kingdom: Academic Press.
DOI Scopus1
2016 Findlay, D. M., Sexton, P. M., & Martin, T. J. (2016). Calcitonin. In J. L. Jameson, L. J. De Groot, & G. C. Weir (Eds.), Endocrinology: Adult and Pediatric (Vol. 1-2, 7th ed., pp. 1004-1017.e5). Philadelphia, PA; USA: Elsevier.
DOI Scopus4
2016 Ostrovskaya, A., Findlay, D., Sexton, P., & Furness, S. (2016). Calcitonin. In Curated Reference Collection in Neuroscience and Biobehavioral Psychology (pp. 220-230). Elsevier.
DOI Scopus5
2015 Gulati, K., Kogawa, M., Maher, S., Atkins, G., Findlay, D., & Losic, D. (2015). Titania nanotubes for local drug delivery from implant surfaces. In D. Losic, & A. Santos (Eds.), Electrochemically Engineered Nanoporous Materials: Methods, Properties and Applications (Vol. 220, pp. 307-355). Switzerland: Springer.
DOI Scopus45
2014 Davey, R., & Findlay, D. (2014). Physiological actions of calcitonin. In B. Nordin, H. Morris, & P. Anderson (Eds.), The Physiological Basis of Metabolic Bone Disease (pp. 187-200). Florida, United States: CRC Press.
2012 Findlay, D. (2012). Subchondral bone in osteoarthritis. In B. Rothschild (Ed.), Principles of Osteoarthritis - its Definition, Character, Derivation and Modality-Related Recognition (1 ed., pp. 139-154). Croatia: InTech.
DOI
2011 Findlay, D., & Atkins, G. (2011). TWEAK and TNF regulation of sclerostin: a novel pathway for the regulation of bone remodelling. In D. Wallach, A. Kovalenko, & M. Feldmann (Eds.), Advances in TNF Family Research (Vol. 691, 1 ed., pp. 337-348). 233 Spring St New York NY 10013: Springer.
DOI Scopus15 WoS12 Europe PMC12
2011 Atkins, G., Findlay, D., Anderson, P., & Morris, H. (2011). Target genes: Bone proteins. In D. Feldman, J. Pike, & J. Adams (Eds.), Vitamin D (Vol. 1, 3rd ed., pp. 411-424). Elsevier.
DOI Scopus26
2011 Atkins, G. J., Findlay, D. M., Anderson, P. H., & Morris, H. A. (2011). Target Genes: Bone proteins. In Vitamin D Two Volume Set (Vol. 1-2, pp. 411-424).
DOI
2010 Martin, T. J., Findlay, D. M., & Sexton, P. M. (2010). Calcitonin. In Endocrinology Adult and Pediatric Sixth Edition (Vol. 1, pp. 1074-1088). Elsevier.
DOI Scopus1
2007 Findlay, D. (2007). Bone. In McGraw-Hill Encyclopaedia of Science and Technology, Vol. 3 (10th ed., pp. 206-208). New York: McGraw-Hill.
2006 Findlay, D., & Haynes, D. (2006). Bone resorption. In Wiley encyclopedia of biomedical engineering (pp. www1-www13). Hoboken, N.J: Wiley.
DOI
2005 Findlay, D., Sexton, P., & Martin, T. (2005). Calcitonin. In L. De Groot, & J. Jameson (Eds.), Endocrinology (5th ed., pp. 1419-1433). Philadelphia, PA: Elsevier Saunders.
DOI
2004 Atkins, G., Findlay, D., Anderson, P., & Morris, H. (2004). Target genes: bone proteins. In D. Feldman, J. Pike, & F. Glorieux (Eds.), Vitamin D, 2nd. ed (Vol. 1, 2nd ed., pp. 711-720). San Diego, California: Elsevier Academic Press.
DOI Scopus4
2004 Atkins, G. J., Findlay, D. M., Anderson, P. H., & Morris, H. A. (2004). Target Genes: Bone Proteins. In Vitamin D Second Edition (pp. 711-720).
DOI
2003 Findlay, D., & Sexton, P. (2003). Calcitonin. In H. Henry, & A. W. Norman (Eds.), Encyclopedia of Hormones (pp. 220-230). San Diego: Academic Press.
DOI
1998 Findlay, D. (1998). Calcitonin and its related proteins. In Calcitonin: Research and clinical applications (pp. 32-38). Life Science Publishing.
1997 Ng, K., Romas, E., Donnan, L., & Findlay, D. (1997). Bone Biology. In Metabolic Bone Disease (Vol. 11, pp. 1-22). WB Saunders Company.
DOI Scopus39 Europe PMC18
1996 Martin, T., Findlay, D., & Moseley, J. (1996). Peptide Hormones Acting on Bone. In Osteoporosis (pp. 185-204). Academic Press.

Year Citation
2019 Kuliwaba, J. S., Lee, Y. -R., Muratovic, D., Gill, T. K., & Findlay, D. M. (2019). BIOCHEMICAL PROFILING OF BONE MARROW LESIONS IN KNEE OSTEOARTHRITIS PATIENTS: ALTERED MINERALIZATION OF THE SUBCHONDRAL BONE MATRIX. In OSTEOARTHRITIS AND CARTILAGE Vol. 27 (pp. S111). Toronto, CANADA: ELSEVIER SCI LTD.
DOI WoS1
2017 Liapis, V., Labrinidis, A., Zinonos, I., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2017). Hypoxia-activated pro-drug Evofosfamide exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. In CLINICAL & EXPERIMENTAL METASTASIS Vol. 34 (pp. 222-223). SPRINGER.
2017 Liapis, V., Zinonos, I., Labrinidis, A., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2017). Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models. In CLINICAL & EXPERIMENTAL METASTASIS Vol. 34 (pp. 222). SPRINGER.
2016 Makar, S., Qin, J., Gulati, K., ElMekawy, A., Kaur, G., Lima-Marques, L., . . . Losic, D. (2016). 3D printed titanium implants with nano-engineered surface titania nanotubes for localized drug delivery. In Chemeca 2016 (pp. 1-12). online: Engineers Australia.
2015 Muratovic, D., Cicuttini, F. M., Wluka, A., Wang, Y., Findlay, D. M., Otto, S., . . . Kuliwaba, J. S. (2015). BONE MARROW LESIONS DETECTED BY DIFFERENT MAGNETIC RESONANCE SEQUENCES AS POTENTIAL BIOMARKERS FOR KNEE OSTEOARTHRITIS: COMPREHENSIVE TISSUE LEVEL ANALYSIS. In OSTEOARTHRITIS AND CARTILAGE Vol. 23 (pp. A303-A305). Seattle, WA: ELSEVIER SCI LTD.
DOI WoS1
2014 Mokhtarzadeh, H., Aw, M., Khalid, K., Gulati, K., Atkins, G., Findlay, D., . . . Pivonka, P. (2014). Computational and experimental model of nano-engineered drug delivery system for trabecular bone. In E. Onate, X. Oliver, & A. Huerta (Eds.), 11th World Congress on Computational Mechanics, WCCM 2014, 5th European Conference on Computational Mechanics, ECCM 2014 and 6th European Conference on Computational Fluid Dynamics, ECFD 2014 (pp. 868-879). Barcelona, Spain: International Center for Numerical Methods in Engineering.
Scopus1
2014 Ormsby, R., Findlay, D., Kogawa, M., Anderson, P., Morris, H., & Atkins, G. (2014). Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling. In D. Bikle, A. Norman, & J. Welsh (Eds.), The Journal of Steroid Biochemistry and Molecular Biology Vol. 144 (pp. 110-113). San Francisco, CA, USA: Elsevier.
DOI Scopus27 WoS25 Europe PMC18
2013 Gulati, K., Atkins, G., Findlay, D., & Losic, D. (2013). Nano-engineered titanium for enhanced bone therapy. In Proceedings of the SPIE 2013 Optics & Photonics Conference Vol. 8812 (pp. 1-6). Online: SPIE-International Society for Optical Engineering.
DOI Scopus26 WoS23
2012 Aw, M., Gulati, K., Atkins, G., Findlay, D., & Losic, D. (2012). Controlling drug release from titania nanotube arrays using polymer nanocarriers and biopolymer coating. In Proceedings of the 10th Asia-Pacific Microscopy Conference, APMC10, the International Conference on Nanoscience & Nanotechnology, ICONN2012 and the 22nd Australian Conference on Microscopy & Microanalysis, ACMM22 (pp. 655-1-655-2). Perth.
2011 Wijenayaka, A. R., Kogawa, M., Lim, H. P., Bonewald, L. F., Findlay, D. M., & Atkins, G. J. (2011). SCLEROSTIN INDUCES OSTEOCYTE SUPPORT OF OSTEOCLAST FORMATION AND OSTEOCLAST ACTIVITY. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S550). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Atkins, G. J., Vincent, C., Wijenayaka, A. R., Welldon, K. J., Haynes, D. R., Zheng, T. S., . . . Findlay, D. M. (2011). THE EFFECTS OF TWEAK AND TNF ON HUMAN OSTEOBLASTS: MAPK DEPENDENT INDUCTION OF SCLEROSTIN EXPRESSION. In D. Wallach, A. Kovalenko, & M. Feldman (Eds.), ADVANCES IN TNF FAMILY RESEARCH Vol. 691 (pp. 688). San Lorenzo del Escorial, SPAIN: SPRINGER-VERLAG BERLIN.
2011 Welldon, K. J., Findlay, D. M., & Atkins, G. J. (2011). CALCIUM AS AN ANABOLIC STIMULUS OF OSTEOBLAST DIFFERENTIATION TO AN OSTEOCYTE-LIKE PHENOTYPE. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S611). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Findlay, D. M., Neale, S. D., Stamenkov, R., & Howie, D. W. (2011). THE NATURAL HISTORY OF PERIACETABULAR OSTEOLYTIC LESIONS. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S615). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Ito, N., Kogawa, M., Wijenayaka, A., Welldon, K., Khalid, K., Ormsby, R., . . . Findlay, D. M. (2011). PHOSPHATE 'SENSING' BY HUMAN BONE. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S585). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Khalid, K. A., Ormsby, R. T., Welldon, K. J., Lim, H. P., Syazwani, S., FatinNabilah, S., . . . Findlay, D. M. (2011). RESPONSE TO LOADING IN EX VIVO BOVINE BONE. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S570). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Kogawa, M., Findlay, D. M., Anderson, P. H., Morris, H. A., & Atkins, G. J. (2011). 25(OH)-VITAMIN D3 ACTS DIRECTLY ON OSTEOCLASTS TO REDUCE RESORPTION: WHAT IS THE MECHANISM?. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S586). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Evdokiou, A., Liapis, V., Hay, S., Keramidas, A., Maltezou, E., Christou, Y., . . . Odysseos, A. (2011). The vitamin E analogue Γ-tocotrienol blocks osteoclastogenesis and promotes osteogenesis: Evidence for combined anti-osteolytic and bone forming activity. In BONE Vol. 48 (pp. S106). Athens, GREECE: ELSEVIER SCIENCE INC.
DOI
2009 Turner, A. G., Tjahyono, F. A., Chiu, W. S. M., Moore, A. J., Findlay, D. M., Morris, H. A., . . . Davey, R. A. (2009). The calcitonin receptor on osteoclasts plays a physiological role to protect against induced hypercalcaemia in mice. In BONE Vol. 44 (pp. S137-S138). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2009 Zinonos, I., Labrinidis, A., Liapis, V., Hay, S., Lee, M., Ponomarev, V., . . . Evdokiou, A. (2009). Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumour growth and osteolysis in murine models of breast cancer development and progression. In BONE Vol. 44 (pp. S54). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2009 Welldon, K. J., Holding, C., Haynes, D. R., Howie, D. W., Findlay, D. M., & Atkins, G. J. (2009). Polyethylene particles activate pro-osteoclastogenic signalling pathways in human primary osteoblasts and osteocytes. In BONE Vol. 44 (pp. S127-S128). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2009 Kogawa, M., Findlay, D. M., Anderson, P. H., Vincent, C., & Atkins, G. J. (2009). The metabolism of 25(OH)-vitamin D<sub>3</sub> by osteoclast precursors regulates the differentiation and function of osteoclasts. In BONE Vol. 44 (pp. S60-S61). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2009 Wijenayaka, A. R., Vincent, C., Findlay, D. M., Welldon, K. J., Zheng, T. S., Haynes, D. R., . . . Atkins, G. J. (2009). The proinflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFa induce the mitogen activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. In BONE Vol. 44 (pp. S63). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI WoS1
2009 Atkins, G. J., Vincent, C., Wijenayaka, A. R., Welldon, K. J., & Findlay, D. M. (2009). TNF-related weak inducer of apoptosis (TWEAK) and sclerostin both signal via Erk-1/2 phosphorylation in human osteoblasts. In BONE Vol. 44 (pp. S56-S57). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI
2008 Anderson, P. H., Atkins, G. J., Sawyer, R. K., Findlay, D. M., O'Loughlin, P. D., & Morris, H. A. (2008). The Requirement of the Bone for Vitamin D for 1,25(OH)<sub>2</sub>D<sub>3</sub> Synthesis and Bone Mineralisation.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 23 (pp. S429). Montreal, CANADA: WILEY-BLACKWELL.
WoS1
2008 Atkins, G. J., Vincent, C., Wijenayaka, A. R., Welldon, K. J., Haynes, D. R., Zheng, T. S., . . . Findlay, D. M. (2008). The Proinflammatory Cytokine TWEAK Induces Sclerostin Expression in Human Immature Osteoblasts in a MAPK Dependent Fashion.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 23 (pp. S385). Montreal, CANADA: AMER SOC BONE & MINERAL RES.
2008 Turner, A. G., Tjahyono, F., Chiu, W. S. M., Moore, A. J., Findlay, D. M., Morris, H. A., . . . Davey, R. A. (2008). The Calcitonin Receptor on Osteoclasts Plays a Physiological Role to Protect Against Hypercalcaemia in Mice. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 23 (pp. S172). Montreal, CANADA: AMER SOC BONE & MINERAL RES.
2007 Atkins, G. J., Vincent, C., Welldon, K. J., Haynes, D. R., Holding, C., Zheng, T. S., . . . Findlay, D. M. (2007). TWEAK is a regulator of human osteoblast function. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 22 (pp. S138). Honolulu, HI: AMER SOC BONE & MINERAL RES.
2007 Ng, D., Tian, W., Withayachumnankul, W., Findlay, D., Ferguson, B., & Abbott, D. (2007). Classification of osteosarcoma T-ray responses using adaptive and rational wavelets for feature extraction. In Derek Abbott (Ed.), Proceedings of SPIE Microelectronics, MEMS, and Nanotechology Vol. 6802 (pp. 1-13). CDROM: SPIE.
DOI Scopus3
2006 Withayachumnankul, W., Ferguson, B., Rainsford, T., Findlay, D., Mickan, S., & Abbott, D. (2006). T-ray relevant frequencies for osteosarcoma classification. In J. M. Bell, & V. K. Varadan (Eds.), Proceedings of Microelectronics, MEMS, and Nanotechnology 2005 Vol. 6038 (pp. 60381H-1-60381H-15). http://www.spie.org/conferences/programs/05/au/: SPIE.
DOI Scopus7 WoS3
2006 Welldon, K., Atkins, G., Vincent, C., & Findlay, D. (2006). Vitamin K analogues promote the differentiation of human osteoblasts.. In Journal of Bone Mineral Research Vol. 21 (pp. SA-204.). Philadelphia, Pennsylvania: American Society for Bone and Mineral Research.
2006 Atkins, G. J., Welldon, K. J., Vincent, C., & Findlay, D. M. (2006). Vitamin K analogues promote the differentiation of primary human osteoblasts.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 21 (pp. S155). Philadelphia, PA: AMER SOC BONE & MINERAL RES.
2006 Zarrinkalam, M. R., Nattrass, G., Beard, H., Atkins, G. J., Findlay, D. M., & Moore, R. J. (2006). Mechanisms of trabecular bone loss in an ovine model of osteoporosis. In OSTEOPOROSIS INTERNATIONAL Vol. 17 (pp. S324). Washington, DC: SPRINGER LONDON LTD.
2006 Findlay, D. M. (2006). Bone physiology and pathology: Complementary insights from non-invasive imaging to tissues to molecules. In Journal of Histotechnology Vol. 29 (pp. 201-202). Informa UK Limited.
DOI
2006 Davey, R. A., Chiu, M. W. S., Moore, A. J., McManus, J. F., Glatt, V., Ma, C., . . . Zajac, J. D. (2006). Trabecular bone volume in young female mice is dependent on calcitonin receptor expression in osteoclasts.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 21 (pp. S196). Philadelphia, PA: AMER SOC BONE & MINERAL RES.
2005 Evdokiou, A., Minh, L. T., Labrinidis, A., Hay, S., Liapis, V., Bouralexis, S., . . . Findlay, D. M. (2005). Apo2L/TRAIL is a potent anticancer agent that prevents breast cancer-induced bone destruction in a mouse model. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 20 (pp. P35). Bethesda, MD: AMER SOC BONE & MINERAL RES.
2005 Davey, R. A., McManus, J. F., Moore, A. J., Chiu, M. W. S., Axell, A. M., Notini, A. J., . . . Zajac, J. D. (2005). Global knock-down of the calcitonin receptor (CTR) results in decreased trabecular bone volume in young female mice.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 20 (pp. S41). Nashville, TN: AMER SOC BONE & MINERAL RES.
2005 Bhattacharyya, S., Siegel, E., Findlay, D. M., Fazzalari, N. L., Chehade, M., Neale, S., . . . Suva, L. J. (2005). Biomarker discovery in osteoarthritis.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 20 (pp. S225). Nashville, TN: AMER SOC BONE & MINERAL RES.
2005 Bouralexis, S., Findlay, D. M., Atkins, G. J., Hay, S., & Evdokiou, A. (2005). Chemotherapy sensitises osteogenic sarcoma cells but not normal cells to trail-induced apoptosis. In CANCER TREATMENT REVIEWS Vol. 31 (pp. S33-S34). Davos, SWITZERLAND: W B SAUNDERS CO LTD.
2005 Findlay, D. M., Howie, D. W., McGee, M. A., Stamenkov, R., Neale, S., Taylor, J. D., . . . Kourlis, G. (2005). Polyethylene wear influences progression of pelvic peri-prosthetic osteolysis. In BONE Vol. 36 (pp. S241-S242). Geneva, SWITZERLAND: ELSEVIER SCIENCE INC.
2005 Atkins, G. J., Kostakis, P., Vincent, C., Farrugia, A. N., Findlay, D. M., Evdokiou, A., & Zannettino, A. C. W. (2005). RANK expression in normal and malignant haemopoietic cells: A monoclonal antibody study.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 20 (pp. S146). Nashville, TN: AMER SOC BONE & MINERAL RES.
2005 Evdokiou, A., Findlay, D. M., Minh, T. L., Labrinidis, A., Hay, S., Liapis, V., . . . Welldon, K. (2005). Apo2L/TRAIL is a potent anti-cancer agent that prevents breast cancer-induced bone destruction in a mouse model. In BONE Vol. 36 (pp. S144). Geneva, SWITZERLAND: ELSEVIER SCIENCE INC.
2005 Dharmapatni, A. A. S. S. K., Findlay, D. M., Smith, M. D., Evdokiou, A., Chen, P., Screaton, G. R., . . . Haynes, D. R. (2005). Regulating the sensitivity of synovial fibroblasts to trail-induced apoptosis. In ANNALS OF THE RHEUMATIC DISEASES Vol. 64 (pp. 154). Vienna, AUSTRIA: BMJ PUBLISHING GROUP.
2005 Kostakis, P., Atkins, G., Vincent, C., Farrugia, A., Findlay, D., Evdokiou, A., & Zannettino, A. (2005). RANK expression in normal and malignant cells: a monoclonal antibody study. In Journal of Bone and Mineral Research Vol. 20 (pp. SA-259.). Nashville, Tennessee: American Society for Bone and Mineral Research.
2004 Atkins, G., Anderson, P., Welldon, K., Zannettino, A., Morris, H., & Findlay, D. (2004). Vitamin D metabolism in human osteoblasts. In Journal of Bone and Mineral Research Vol. 19 (pp. SA-587). Seattle, Washington: American Society for Bone and Mineral Research.
2004 Ferguson, B., Liu, H., Hay, S., Findlay, D., Zhang, X., & Abbott, D. (2004). In vitro osteosarcoma biosensing using THz time domain spectroscopy. In L. Faraone, & V. K. Vardan (Eds.), Proceedings of SPIE on CD-Rom Vol. 5275 (pp. 304-316). CD-ROM: SPIE.
DOI Scopus14 WoS11
2004 Labrinidis, A., Nguyen, O. K., Bouralexis, S., Hay, S., Findlay, D. M., & Evdokiou, A. (2004). Inhibitors of the mevalonate pathway sensitize osteosarcoma cells to Apo21/trail-induced cell death. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 19 (pp. 1572). San Antonio, TX: AMER SOC BONE & MINERAL RES.
2004 Atkins, G. J., Anderson, P. H., Welldon, K., Zannettino, A. C. W., Morris, H. A., & Findlay, D. M. (2004). Vitamin D metabolism in human osteoblasts.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 19 (pp. S204). Seattle, WA: AMER SOC BONE & MINERAL RES.
2004 Lucas, H., Zreiqat, H., Gross, K. A., Holding, C., Findlay, D. M., Wallwork, M., & Haynes, D. R. (2004). Osteoclast resorption of hydroxyapatite bone substitute materials in vitro. In Transactions 7th World Biomaterials Congress (pp. 1309).
2003 Atkins, G. J., Anderson, P. H., Morris, H. A., Zannettino, A. C. W., Kostakis, P., & Findlay, D. M. (2003). The expression of 25-hydroxyvitamin D 24-hydroxylase and 25-hydroxyvitamin D 1 alpha-hydroxylase in human osteoblasts.. In JOURNAL OF BONE AND MINERAL RESEARCH Vol. 18 (pp. S409). MINNEAPOLIS, MINNESOTA: AMER SOC BONE & MINERAL RES.
2003 Dassios, H., Findlay, D. M., Kuliwaba, J. S., Atkins, G. J., & Fazzalari, N. L. (2003). Enhanced gene expression of osteoclastogenic factors in human osteoporotic trabecular bone. In BONE Vol. 32 (pp. S149). OSAKA, JAPAN: ELSEVIER SCIENCE INC.
2003 Pan, B. Q., To, L. B., Farrugia, A. N., Kostakis, P., Atkins, G. J., Findlay, D. M., & Zannettino, A. C. W. (2003). Multiple myeloma-derived pro-inflammatory cytokines enhance osteoclastogenesis by increasing the number of RANKL-expressing STRO-1 positive osteoprogenitor cells.. In BLOOD Vol. 102 (pp. 370B). SAN DIEGO, CALIFORNIA: AMER SOC HEMATOLOGY.
2003 Kostakis, P., Atkins, G., Pan, B., Farrugia, A., Gronthos, S., Evdokiou, A., . . . Zannettino, A. (2003). The relationship between RANKL expression and osteoblast differentiation in human osteoblasts. In 30th European Symposium on Calcified Tissues, 8-12 May 2003 Vol. Italy (pp. 314-468). Rome, Italy: Springer Science and Business Media LLC.
DOI
2002 Atkins, G., Zannettino, A., Kostakis, P., Pan, B., Farrugia, A., Evdokiou, A., & Findlay, D. (2002). Evidence for the maturation-dependent expression of an osteoclastogenic phenotype in human osteoblasts.. In Journal of Bone and Mineral Research Vol. 17 (pp. S446.). San Antonio, Texas: American Society for Bone and Mineral Research.
2002 Atkins, G., Pan, B., Findlay, D., To, L., Evdokiou, A., Labrinidis, A., . . . Zannettino, A. (2002). Zoledronate is anabolic for human osteoblast-like cells. In Journal of Bone and Mineral Research Vol. 17 (pp. S442.). San Antonio, Texas: American Society for Bone and Mineral Research.
2001 Atkins, G., Kuliwaba, J., Findlay, D., Forwood, M., & Fazzalari, N. (2001). Differential Gene Expression in the Human Bone Microenvironment of the Hip; Comparison Between Control and Osteoarthritis.. In Journal of Bone and Joint Surgery (Br.) Vol. 84-B (pp. 235). Adelaide, South Australia: The British Editorial Society of Bone and Joint Surgery.
1999 Crotti, T. N., Potter, A. E., Atkins, G. J., Findlay, D. M., Howie, D. W., & Haynes, D. R. (1999). Osteoclast differentiation and development is regulated by mediators released in response to prosthetic particles. In H. Stein, S. I. Suk, P. C. Leung, K. G. Thorngren, & W. Akeson (Eds.), SIROT 99 (pp. 542-546). SYDNEY, AUSTRALIA: FREUND PUBL HOUSE LTD.
1999 Kuliwaba, J. S., Findlay, D. M., Atkins, G. J., Forwood, M. R., & Fazzalari, N. L. (1999). Gene expression in osteoarthritic cancellous bone is consistent with osteoarthritis being a disease of the skeleton. In H. Stein, S. I. Suk, P. C. Leung, K. G. Thorngren, & W. Akeson (Eds.), SIROT 99 (pp. 437-441). SYDNEY, AUSTRALIA: FREUND PUBL HOUSE LTD.
1999 Atkins, G. J., Loric, M., Crotti, T. N., Haynes, D. R., & Findlay, D. M. (1999). Osteoclast differentiation factors are expressed by both stromal and haematopoietic cells in human osteoclast formation. In H. Stein, S. I. Suk, P. C. Leung, K. G. Thorngren, & W. Akeson (Eds.), SIROT 99 (pp. 547-551). SYDNEY, AUSTRALIA: FREUND PUBL HOUSE LTD.
1995 Martin, T. J., Findlay, D. M., Houssami, S., Ikegame, M., Rakopoulos, M., Moseley, J. M., & Sexton, P. M. (1995). Heterogeneity of the calcitonin receptor: Functional aspects in osteoclasts and other sites. In Journal of Nutrition Vol. 125 (pp. 2009S-2014S). United States: Elsevier BV.
DOI Scopus10 Europe PMC6
1990 Ng, K. W., Manji, S. S., Young, M. F., & Findlay, D. M. (1990). Interaction of retinoic acid and other factors on transcriptional activity of pre-osteoblasts. In Calcium regulation and bone metabolism. Basic and clinical aspects: proceedings of the 10th International Conference on calcium regulating hormones and bone metabolism. ICS886 (pp. 311-316).
1990 Sexton, P. M., D'Santos, C. S., Mendelsohn, F. A. O., Schneider, H. G., Findlay, D. M., Kemp, B. E., & Moseley, J. M. (1990). Characterization of sheepbrain calcitonin receptors. In Calcium Regulation and Bone Metabolism Basic and Clinical Aspects Proceedings of the 10th International Conference on Calcium Regulating Hormones and Bone Metabolism Ics886 (pp. 57-63).
Scopus3
1977 Caruso, G., Findlay, D. M., Alford, F. P., Dudley, F., & Chisholm, D. J. (1977). THE MULTIPLE FORMS OF CIRCULATING “GLUCAGON”. In Australian and New Zealand Journal of Medicine Vol. 7 (pp. 686). Wiley.
DOI

Year Citation
2021 Muratovic, D., Findlay, D. M., Masri, H. H., Stapledon, C. J., Lee, Y., Cao, X., . . . Kuliwaba, J. S. (2021). ELEVATED LEVELS OF ACTIVE TRANSFORMING GROWTH FACTOR beta 1 IN THE SUBCHONDRAL BONE RELATE SPATIALLY TO IMPAIRED BONE QUALITY AND CARTILAGE LOSS IN HUMAN KNEE OSTEOARTHRITIS. Poster session presented at the meeting of OSTEOARTHRITIS AND CARTILAGE. ELSEVIER SCI LTD.
DOI
2017 Liapis, V., Labrinidis, A., Zinonos, I., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2017). Anticancer efficacy of the hypoxia-activated pro-drug evofosfamide in prcelinIcal osteosarcoma murine models. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. SPANDIDOS PUBL LTD.
2017 Liapis, V., Zinonos, I., Labrinidis, A., Hay, S., Ponomarev, V., Panagopoulos, V., . . . Evdokiou, A. (2017). The hypoxia activated pro-drug evofosfamide exhibits tumour suppressive activity and synergy with chemotherapy against primary and metastatic breast cancers. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. SPANDIDOS PUBL LTD.
2014 Kuliwaba, J. S., Lee, Y. -R., Naas, S., Muratovic, D., Humphries, J. M., & Findlay, D. M. (2014). THE PATHOPHYSIOLOGY OF SUBCHONDRAL CANCELLOUS BONE IN POSTMENOPAUSAL KNEE OSTEOARTHRITIS: DIFFUSE MICRODAMAGE ACCUMULATION, OSTEOCYTE CELL DEFICIENCY AND BONE MARROW HYPERVASCULARITY. Poster session presented at the meeting of OSTEOARTHRITIS AND CARTILAGE. Paris, FRANCE: ELSEVIER SCI LTD.
DOI
2009 Labrinidis, A., Hay, S., Liapis, V., Findlay, D. M., & Evdokiou, A. (2009). Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model. Poster session presented at the meeting of CLINICAL & EXPERIMENTAL METASTASIS. SPRINGER.
WoS2
2003 Anderson, P., Atkins, G., Morris, H., Kostakis, P., Findlay, D., & Zannettino, A. (2003). The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblasts.. Poster session presented at the meeting of Calcified Tissue International. Rome, Italy: Springer.
2003 Atkins, G., Anderson, P., Morris, H., Zannettino, A., Kostakis, P., & Findlay, D. (2003). The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblasts. Poster session presented at the meeting of Journal of Bone Mineral Research. Minnesota, USA.

Year Citation
2020 Solomon, L. B., Atkins, G., Freeman, B., Howie, D., Findlay, D., Smitham, P., . . . Jones, C. (2020). COTR publications [website]. University of Adelaide: Dan McCafferty.

Year Citation
2021 Hofstaetter, J., Atkins, G., Kogawa, M., Blouin, S., Misof, B., Roschger, P., . . . Ito, N. (2021). A case of autosomal dominant osteopetrosis type II with a severe bone phenotype but no amino acid converting mutation in the <i>CLCN7</i> gene.
DOI

Date Role Research Topic Program Degree Type Student Load Student Name
2016 - 2019 Co-Supervisor The Role of the Osteocyte in Periprosthetic Osteolysis Doctor of Philosophy Doctorate Full Time Ms Renee Ormsby
2015 - 2019 Principal Supervisor The establishment of an automated, electronic data-collection system for the purpose of qualifying, evaluating and improving post-operative surgical outcomes and evidence-based surgery Doctor of Philosophy Doctorate Part Time Dr James Marcus McLean
2014 - 2017 Principal Supervisor Evaluation of Low Grade Bacterial Infection of the Intervertebral Disc Master of Philosophy (Surgery) Master Part Time Thomas James Fisher
2013 - 2018 Co-Supervisor Bone Marrow Lesions in Progression of Knee Osteoarthritis Doctor of Philosophy Doctorate Full Time Dr Dzenita Muratovic
2012 - 2015 Co-Supervisor Nano-Engineered Titanium Implants for Complex Bone Therapies Doctor of Philosophy Doctorate Full Time Mr Karan Gulati
2011 - 2012 Co-Supervisor The Effect of Bone Anabolic Stimuli on Human Osteoblast to Osteocyte Transition Master of Philosophy (Medical Science) Master Full Time Ms Katie Welldon
2010 - 2014 Co-Supervisor The regulation of the sclerostin gene and the catabolic effects of sclerostin protein on bone Doctor of Philosophy Doctorate Full Time Dr Asiri Wijenayaka
2009 - 2019 Co-Supervisor Ex Vivo Bone Culture: A Novel Method for Investigating Mechanical Loading Response and Osteocytes in Situ In Trabecular Bone Doctor of Philosophy Doctorate Full Time Dr Kamarul Ariffin Khalid
2007 - 2009 Principal Supervisor An Anatomical Basis for the Management of Complex Wrist Injuries Master of Surgery Master Part Time Dr James Marcus McLean
2007 - 2012 Co-Supervisor The Effectsof the Histone Deacetylase Inhibitor LBH589 on Breast Cancer in Bone and on Physiological Bone Remodelling Doctor of Philosophy Doctorate Full Time Ms Michelle Lee
2003 - 2007 Co-Supervisor Apo 2L/TRAIL in Breast Cancer Bone Metastasis: in vitro and in vivo Studies into Molecular Mechanisms of Action and Resistance Doctor of Philosophy Doctorate Full Time Mr Le Thai
2003 - 2007 Co-Supervisor Trail Mediated Apoptosis in Arthritis Doctor of Philosophy Doctorate Full Time Ms Anak Dharmapatni
2002 - 2009 Co-Supervisor Computed Tomography Technique for the Measurement of Bone Defects Adjacent to Uncemented Acetabular Components of Total Hip Replacement Master of Surgery Master Part Time Dr Roumen Botev Stamenkov
2000 - 2003 Principal Supervisor Molecular Mechanisms of Apo2L/TRAIL Induced Apoptosis In Normal and Malignant Cells Doctor of Philosophy Doctorate Full Time Mr Stelios Bouralexis
1999 - 2003 Co-Supervisor GENE EXPRESSION, BONE REMODELLING, AND MICRODAMAGE IN THE HUMAN PROXIMAL FEMUR: A MOLECULAR HISTOMORPHOMETRIC ANALYSIS OF OSTEOARTHRITIC BONE Doctor of Philosophy Doctorate Full Time Dr Julia Kuliwaba
1999 - 2002 Co-Supervisor MEDIATORS OF LOCALISED PATHOLOGICAL BONE LOSS Doctor of Philosophy Doctorate Full Time APrf Tania Crotti

Connect With Me

External Profiles

Other Links